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ABSTRACT
 The efficiency of metazoan origins of DNA replication is known to be enhanced 
by histone acetylation near origins. Although this correlates with increased MCM 
recruitment, the mechanism by which such acetylation regulates MCM loading is 
unknown. We show here that Cdt1 induces large-scale chromatin decondensation that is 
required for MCM  recruitment. This process occurs in G1, is suppressed by  Geminin, and 
requires HBO1 HAT activity and histone H4 modifications. HDAC11, which binds Cdt1 
and replication origins during S-phase, potently inhibits Cdt1-induced chromatin 
unfolding and re-replication, suppresses MCM  loading, and binds Cdt1 more efficiently 
in the presence of Geminin. We also demonstrate that chromatin at endogenous origins is 
more accessible in G1 relative to S-phase. These results provide evidence that histone 
acetylation promotes MCM  loading via enhanced chromatin accessibility. This process is 
regulated positively by Cdt1 and HBO1 in G1 and repressed by Geminin-HDAC11 
association with Cdt1 in S-phase, and represents a novel form of replication licensing 
control.
ix
CHAPTER 1
INTRODUCTION
Cancer
 Cancer is not one specific disease, but  instead is a grouping of over 100 distinct 
diseases that share the fundamental characteristics of uncontrolled cellular growth and 
invasiveness (Stratton et al. 2009).  Individual cancer cells escape the biological 
regulatory mechanisms that control normal cellular proliferation leading to their 
accumulation and dissemination (Collins et al. 1997; Frank 2007).  The spread of 
cancerous cells ignores anatomical constraints, utilizing physical and chemical means to 
invade surrounding tissues and metastasize to other areas of the body (Kufe et al. 2003; 
Folkman 2006).  Since tumor size is directly  proportionate to nutrient and oxygen 
demand, angiogenesis, or neovascularization, is required to support  the growth of a tumor 
and its metastatic colonies (Folkman 2006).  Tumor expansion, therefore, negatively 
affects the normal function of organs not only by  physical disruption due to increasing 
mass, but also by robbing neighboring tissues of nutrients and oxygen.   Without 
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intervention, the malignant nature of these neoplasms ultimately leads to death (Kufe et 
al. 2003).  
 Currently, cancer ranks behind only heart disease as the leading cause of mortality 
both in the United States and worldwide.  Nearly  one in every four deaths in the United 
States and more than one in every ten deaths worldwide are a direct result of invasive 
tumors.  As an indication of how commonplace cancer is, especially  in developed nations, 
the lifetime probability  of developing invasive tumors for American men and women are 
a daunting 44% and 37%, respectively (American Cancer Society 2009).  
 The high incidence of occurrence and mortality has propelled cancer to the 
forefront of medical research, however the complexity and heterogeneity of these 
diseases have impeded the progress towards efficacious treatments, let  alone cures. 
Tumors can arise from nearly every cell type and organ within the human body, 
encompassing a broad-spectrum of differing cellular biologies. Although every tumor 
type encapsulates different causal mechanisms that involve differing hereditary and 
environmental factors, one shared characteristic underlying the transformation of a 
normal cell into a tumor cell is the alteration of the genome (Stratton et al. 2009).  
Genomic Instability in Cancer
 The transformation of a normal cell to a tumor cell is a complex process that 
involves circumventing the many safeguards inherently  in place that prevent such a 
negative event from occurring (Hanahan and Weinberg 2000).  The genetic material of a 
cell is the fundamental blueprint upon which all cellular processes and controls are based, 
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therefore maintaining genomic integrity is of the utmost importance.  Improper 
alterations of the genome, ranging from point mutations to chromosomal rearrangements 
to gains and losses of genetic material, are known collectively as genetic instability  and 
are associated with the vast majority of cancers (Collins et al. 1997; Negrini et al. 2010). 
In cancer cells, genomic instability commonly emerges as chromosome translocations, 
gene amplifications, aneuploidy, and polyploidy.  The ultimate result of such genetic 
changes result in phenotypic shifts that are favorable to growth and proliferation, while 
genes encoding growth inhibitory proteins are often compromised (Lengauer et  al. 1998; 
Negrini et al. 2010).  Genomic instability  often arises out of defects in mitotic control, 
DNA repair, telomere control, and DNA replication (Cahill et al. 1998; Blow and 
Gillespie 2008).  The basis of this research project was to investigate one such 
mechanism of control that is associated with proper assembly  of the proteins involved in 
DNA replication initiation. 
Loss of Proliferative Control
 The propelling force in cancer development is the loss of control of the underlying 
mechanisms responsible for regulating cellular proliferation, also known as the cell 
division cycle (Hanahan and Weinberg 2000; Evan and Vousden 2001).   As such, 
regulatory vigilance of the cell division cycle at  the molecular level is necessary to 
prevent any minute deviations that may contribute to the transformation of a normal cell 
into a neoplastic one.  Extracellular growth signals and intracellular signaling cascades 
act in a concerted manner to coordinate cellular growth by  regulating the downstream cell 
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cycle machinery.  The fundamental steps of the cell cycle include copying parental DNA 
(S-phase), physical division of the two daughter nuclei (Mitosis), and the periods 
separating these events (Gap  phases, G1 precedes S-phase and G2 precedes M).  While 
each of these phases is tightly regulated, the control of the G1-S transition is of particular 
importance (Hartwell and Kastan 1994; Hook et al. 2007).  During this period, the 
controlled assembly of the pre-Replication Complex and subsequent loading of the MCM 
helicase represents an essential regulatory mechanism and proper control of this step is 
crucial to ensuring the fidelity and timing of genome replication (Vaziri et al. 2003; Hook 
et al. 2007).  Elucidating a novel molecular mechanism by which cells regulate MCM 
helicase loading, and thereby maintaining proper G1-S control, is the focus of this 
research project.  
Cell Cycle
 To proliferate, individual cells must duplicate themselves via a series of 
coordinated events known collectively  as the cell cycle (Norbury and Nurse 1992).  In its 
essence, the cell cycle involves two basic processes: a single round of DNA replication in 
which the entire genome of a cell is copied and the segregation of the replicated 
chromosomes into two separate daughter cells (Collins et al. 1997).  During the cell 
division cycle, DNA is replicated during the synthesis phase (S-phase) and the two copies 
of each chromosome are segregated into daughter nuclei during mitosis (M-phase) 
(Norbury  and Nurse 1992).  This is followed by the separation of the cytoplasm into two 
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daughter cells, a process known as cytokinesis, which represents the final step  of the cell 
cycle.  
 S-phase and M-phase are separated temporally  by what are known as gap  phases, 
G1 occurs between M-phase and S-phase while G2 occurs between S-phase and M-
phase.  During these gap  phases, cells prepare for entry  into either S-phase or M-phase 
and gather information from throughout the cell to determine its readiness to progress to 
the next phase (Pardee 1989; Johnson and Walker 1999).  
 Cell cycle progression is controlled by  two major mechanisms.  The first 
mechanism of regulation involves a cascade of phosphorylation events modulated by a 
group of heterodimeric protein kinases, which drives the cell cycle forward.  The 
activation of these kinases requires the physical association of a regulatory subunit, called 
a cyclin, with a catalytic subunit, or cyclin-dependent kinase (CDK) (Pardee 1989; 
Norbury  and Nurse 1991).  The substrate specificity of this activated complex derives 
from the specific combination of cyclin and CDK.  The cellular levels of cyclins increase 
and decrease in concert with progression through the cell cycle as different cyclin-CDK 
combinations are required during the different stages of the cell cycle.  The second 
mechanism by  which the cell cycle is regulated is known as checkpoint control (Collins 
et al. 1997).  Cell cycle checkpoints integrate sensory signals from within the cell to 
determine if the processes of each cell cycle phase has been properly completed before 
progression is permitted (Johnson and Walker 1999).  In a sense, checkpoints play  a 
supervisory role and sense imperfections in cell cycle processes that could lead to 
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imprecise replication of DNA or flawed segregation of chromosomes potentially resulting 
in unequal daughter cells or other mutations (Collins et al. 1997).   
 The cell cycles of normal dividing cells are tightly regulated and coordinated to 
ensure faithful reproduction of the parental cells.  Cancer cells must also utilize the cell 
cycle machinery  in order to proliferate and grow, however the regulatory mechanisms of 
the cell cycle are often altered to permit the uncontrolled growth that is inherent to 
neoplasia (Cahill et al. 1998; Lengauer et al. 1998).  
 
DNA Replication
 Cellular proliferation requires the faithful duplication of the parental genome 
during the S-phase of the cell division cycle to ensure that each daughter cell receives an 
exact copy of the mother cell’s genetic material (Dutta and Bell 1997; Bell and Dutta 
2002; Masai et al. 2010).  Imprecision during the replication of parental template DNA 
can potentially  lead to alterations in the genome that favor cancer development (Blow 
and Gillespie 2008).  Due to the size of the genetic template, DNA replication initiates 
from thousands of separate genomic regions known as origins of replication.  The DNA 
that is replicated from a single origin of replication is known as a replicon (Huberman 
1995).  Mammalian somatic cells have large replicons that range in size from 50-kb to 
500-kb and these replicons appear to replicate in clusters and in a staggered manner such 
that not all active origins fire simultaneously at  the onset of S-phase (Berezney et al. 
2000; Ge et  al. 2007; Cadoret et al. 2008).  Furthermore, in a given S-phase, not all 
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licensed preRCs are activated, as many are kept in reserve and only  fire in response to 
replicative stresses (Ge et al. 2007). 
Fig. 1 The Pre-Replication Complex.  The preRC is required for the initiation of 
replication at a given replication origin.  The preRC is comprised of an ORC hexamer, 
which recruits Cdt1 and Cdc6 to the origin of replication.  Cdt1 and Cdc6 are required to 
load the MCM complex, which serves as the putative replicative helicase.  Once the 
MCM helicase is loaded, the preRC is considered to be licensed for replication.
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 Initiation of DNA replication requires the stepwise assembly of a macromolecular 
complex of proteins known as the pre-Replication Complex (preRC) during G1-phase of 
the cell cycle (Fig. 1).  The hexameric origin recognition complex (ORC) binds to the 
origins of replication on DNA, forming the foundation of the preRC.  ORC then recruits 
Cdt1 and Cdc6, which are both required to load the hexameric Mini-Chromosome 
Maintenance (MCM) helicase complex, comprised of Mcm2-7, onto DNA (Bell and 
Dutta 2002; Mendez and Stillman 2003).  Once loaded, the MCM  complex is believed to 
serve as the replicative helicase or act at the initial DNA unwinding step, or both (Chong 
et al. 2000; Shechter et al. 2004).  At the G1-S transition, Cdk2 and Cdc7 kinases are 
activated and Mcm10, Cdc45, and DNA polymerase α/primase are recruited, initiating 
bidirectional nascent strand synthesis from the origin (Fig. 2), or preRC site (Mendez and 
Stillman 2003; Masai et al. 2010).   
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Fig. 2 Origin of Replication during G1-S.  PreRCs at origins of replication are licensed 
during G1-phase.  ORC recruits, Cdt1 and Cdc6, which in turn load the MCM  helicase 
onto chromatin.  At the G1-S transition, there is an increase in cellular CDK activity, and 
Cdc45, Mcm10, and DNA polymerases are recruited to the activated origins, which is 
followed by bidirectional nascent strand synthesis. 
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 After DNA replication initiation, two replication forks originate from a single 
activated preRC and origin of replication.  As the replicative helicase unwinds and 
separates the DNA substrate, RPA binds the single stranded DNA and DNA polymerase 
α/primase is loaded in a process termed primosome assembly, as reviewed by Waga and 
Stillman (Waga and Stillman 1998) and depicted in Figure 3.  Mcm10 and Cdc45 are 
necessary  for the loading and retention of pol α/primase onto chromatin (Waga and 
Stillman 1998; Garg and Burgers 2005).  Since DNA polymerases can only extend 
existing oligonucleotides and not create them de novo, pol α/primase serves an important 
role in fork progression as it is able to synthesize short RNA primers complementary  to 
the parental DNA strand and then extend them by approximately 20 nucleotides. 
Polymerase switching then occurs and other, more processive polymerases can take over 
allowing replication to continue (Garg and Burgers 2005).  
 DNA polymerases only synthesize DNA in the 5’ to 3’ direction, as such within 
any given replication fork, one strand will be copying DNA in the same direction of 
helicase unwinding, termed the leading strand (Fig. 3).  The other strand, termed the 
lagging strand, will copy its template in a more discontinuous fashion.  Replication of the 
leading strand is performed by DNA polymerase ε (Pursell et  al. 2007), in a process that 
is inherently faster than lagging strand synthesis.  To rectify  this, pol α/primase also acts 
as a molecular brake for pol ε synthesis as a mechanism to coordinate leading strand and 
lagging strand synthesis (Lee et al. 2006).  Lagging strand replication is performed by 
DNA polymerase δ and, unlike the leading strand, lagging strand synthesis requires 
frequent priming by  pol α/primase (Fig. 3).  Thus, lagging strand synthesis has several 
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discrete steps: synthesis of an RNA primer by  pol α/primase, subsequent extension of this 
primer by the polymerase subunit of pol α/primase, polymerase switching to allow for pol 
δ to continue synthesis, excision of the RNA primers by FEN1 or RNase HI, gap filling 
by pol δ, and then nick sealing by DNA Ligase I (Waga and Stillman 1998; Garg and 
Burgers 2005).  The latter three steps described here are known as Okazaki Fragment 
Maturation and occurs 20-50 million times in every mammalian cell cycle (Garg and 
Burgers 2005).  PCNA, or Proliferating Cell Nuclear Antigen, plays an important role in 
DNA replication elongation by acting as a processivity factor for pol δ and pol ε and is 
loaded onto the DNA by RFC in an ATP-dependent manner (Tsurimoto and Stillman 
1990; Waga and Stillman 1998; Garg and Burgers 2005).
 The assembly of preRCs is subject to numerous limitations, especially with 
respect to the timeframe when assembly can occur during the cell cycle in order to 
prevent replication origins from firing more than once.  Collectively, this control over 
preRC assembly and MCM  loading is known as “replication licensing” and is completed 
once the MCMs are loaded (Blow 1993; Blow 2001; Blow and Hodgson 2002).  In fact, 
once the complex of MCMs has been recruited, ORC and Cdc6 (and likely Cdt1) are no 
longer required for origin firing and S-phase progression.   
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Fig. 3 The Replication Fork.  Initiation of DNA replication involves the generation of 
two replication forks moving in opposite directions from an activated origin of 
replication.  One such replication fork is depicted, which includes a leading strand that 
synthesizes DNA in the direction of fork progression, and a lagging strand that is forced 
to replicate DNA in a discontinuous fashion due to the unidirectional nature of 
polymerases.
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Origin Recognition Complex
 The evolutionarily conserved, hexameric Origin Recognition Complex (ORC) 
binds directly to DNA and acts as the initiator of DNA replication.  ORC was initially 
identified in S. cerevisiae budding yeast and demonstrated binding specificity  to the 
autonomously replicating sequence (ARS) via the A-element (or ARS consensus 
sequence), which contains the origins of replication in yeast (Bell and Stillman 1992; Loo 
et al. 1995).  ORC has since been found to be a vital component in all eukaryotic DNA 
replication, however, unlike in yeast, a specific binding site or sequence does not seem to 
exist in other organisms (Mendez and Stillman 2003; Vashee et al. 2003; Masai et al. 
2010).   Instead, ORC binding to origins of replication in higher eukaryotes seems to be 
more plastic and occurs in zones rather than at discrete sites (Hamlin et  al. 2010).  Orc2-5 
stably  bind to chromatin through the cell cycle, while Orc1 seems to be bound only 
during G1 and becomes degraded during progression through S-phase (Ohta et al. 2003; 
Tatsumi et al. 2003).  
 Orc1, Orc4, and Orc5 belong to the AAA+ (ATPases associated with a variety of 
cellular activities) family of proteins and ATP binding stimulates ORC association with 
DNA (Giordano-Coltart et al. 2005; Duncker et al. 2009).    Once ATP bound ORC has 
loaded onto chromatin, it serves as an anchoring point for the remainder of the preRC 
proteins to bind to.  ATP hydrolysis by ORC is necessary for reiterative loading of 
preRCs onto chromatin (Bowers et al. 2004).
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Cdc6
 Cdc6, or Cell Division Cycle 6, was initially identified in S. cerevisiae and is 
indispensable for the loading of MCMs and preRC licensing (Bell and Dutta 2002; Cook 
et al. 2002).  Cdc6 shows sequence similarity  to subunits of clamp-loaders in both 
eukaryotes and prokaryotes and have functionally been shown to be involved in the 
loading of Mcms onto chromatin (Perkins and Diffley 1998).  Similar to several of the 
ORC components, Cdc6 is an ATPase that belongs to the AAA+ family of proteins 
(Randell et  al. 2006).  Once ORC binds to the origin of replication, Cdc6 complexed to 
ATP is then recruited to the site of preRC assembly along with Cdt1 to load Mcm2-7. 
Cdc6 then hydrolizes ATP which results in both Cdc6 and Cdt1 dissociation from the 
preRC but simultaneously stabilizes the MCM complex to chromatin (Randell et al. 
2006).  
 Cdc6 is regulated by several mechanisms.  Phosphorylation of S. cerevisiae Cdc6 
(and its S. pombe fission yeast homolog Cdc18p) by CDKs results in ubiquitin-dependent 
proteasomal degradation, while Cdc6 phosphorylation in X. laevis results in export  from 
the nucleus (Pelizon et al. 2000; Cook et al. 2002).  Interestingly, phosphorylation of 
human Cdc6 has the opposite effect and leads to protein stability by preventing APC/C 
E3 ubiquitin ligase-dependent proteolysis (Mailand and Diffley 2005).  
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Cdt1
 Cdt1, CDC10 dependent transcript 1, was initially  identified in S. pombe as an 
essential gene product  of cdc10 (Hofmann and Beach 1994).  Cdt1 is highly conserved 
(Bell and Dutta 2002) and homologs have since been identified in many  eukaryotic 
species including humans (Wohlschlegel et  al. 2000), mice (Arentson et al. 2002), S. 
cerevisiae (Tanaka and Diffley 2002), X. laevis (Maiorano et  al. 2000), and Drosophila 
(Whittaker et al. 2000).   CDT1 is an essential gene as its product is required for 
chromosomal DNA replication (Maiorano et al. 2000) and mutations result in a DNA 
synthesis block and errors in the S-phase checkpoint (Hofmann and Beach 1994).  Cdt1 is 
loaded onto chromatin prior to DNA replication in an ORC dependent manner as an 
integral part of the pre-Replication Complex and is required to load the MCM2-7 protein 
hexamer (Maiorano et  al. 2000).  In S. pombe, Cdt1 has been shown to physically interact 
with the C-terminus of Cdc6 and together they act to cooperatively promote the 
association of MCM proteins on chromatin (Nishitani et al. 2000).  Furthermore, Cdt1 is 
known to bind several DNA replication proteins directly, including PCNA (Tsurimoto 
1999), Mcm4 (Cook et al. 2004), and Mcm6 (Yanagi et al. 2002) (Fig. 4).
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Fig. 4 Schematic of Cdt1.  Cdt1 serves as a scaffolding protein that interacts with many 
different proteins.  Shown here is the C-terminal Cdt1 interaction with the MCM 
helicase.  The central portion of Cdt1 is responsible for the bipartite interaction with 
Geminin and the interaction with HDAC11.  The N-terminal region of Cdt1 contains the 
PIP box for PCNA interaction and Cy motif for Cyclin/Cdk binding, both of which 
mediate polyubiquitination by distinct E3 ligases.  The HBO1 binding region of Cdt1 has 
yet to be defined. 
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 Cdt1 is regulated by a small protein called Geminin (Wohlschlegel et al. 2000). 
Initial reports demonstrated that  Geminin acts to inhibit Cdt1 function (Wohlschlegel et 
al. 2000; Yanagi et al. 2002), however, more recent evidence indicates Geminin acts also 
in a positive manner to facilitate Cdt1 function (Lutzmann et al. 2006; Xouri et al. 2007). 
This dual role of Cdt1 regulation by Geminin is determined by  the stoichiometric ratio of 
Geminin to Cdt1 within the complex where a high Geminin:Cdt1 ratio acts in an 
inhibitory manner whereas a low Geminin:Cdt1 ratio facilitates Cdt1 function.  The ratio 
of Geminin binding to Cdt1 increases to become inhibitory  after origin firing, presumably 
to prevent improper MCM loading by Cdt1 (Lutzmann et al. 2006).  
 It is of great importance that MCM loading be limited to once during any given 
cell cycle.  As such, Cdt1 activity is restricted to only G1-phase of the cell cycle and this 
activity is tightly  regulated.  In addition to Geminin, Cdt1 is also controlled by several 
other mechanisms that regulate its stability  (Fujita 2006).  Cyclin dependent kinases 
(CDKs) represent another layer of Cdt1 control (Fujita 2006).  As S-phase begins, there is 
an increase in CDK activity (Bell and Dutta 2002) which results in the phosphorylation of 
Cdt1 on its N-terminal cyclin-binding motif by cyclin A-dependent kinases (Liu et al. 
2004; Sugimoto et al. 2004).  This phosphorylation triggers Cdt1 polyubiquitination by 
the SCFSkp2 E3 ubiquitin ligase complex and subsequent targeting to proteasome-
mediated degradation during S-phase and G2 (Li et al. 2003; Nishitani et al. 2006). 
Moreover, phosphorylated Cdt1 is also impaired in its ability  to bind DNA, 
demonstrating multiple mechanisms by which CDKs are able to control Cdt1 function 
(Sugimoto et al. 2004).  Cdt1 is further regulated by a second E3 ubiquitin ligase 
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pathway, independent of SCFSkp2.  During S-phase or after DNA damage, Cdt1 is targeted 
for proteasomal degradation by  binding to PCNA via an N-terminal motif, which results 
in ubiquitination by the Cul4/Ddb1 E3 ligase (Hu et al. 2004; Hu and Xiong 2006; 
Nishitani et al. 2006; Senga et al. 2006) (Fig. 4).
 The multiple levels of control over Cdt1 are important factors in the overall 
regulation of replication licensing.  Controlling MCM chromatin loading is of critical 
importance to the cell in that it allows one and only one round of DNA replication to 
occur, and prevents the inappropriate reloading of MCMs and subsequent re-replication 
(i.e., relicensing) that can cause genomic instability.  Improper overexpression of Cdt1 
(Vaziri et al. 2003) or Geminin depletion (Melixetian et al. 2004; Zhu et al. 2004) can 
lead to re-replication, demonstrating the importance of Cdt1 regulation.  In fact, Cdt1 can 
act as an oncogene and is found to be overexpressed in several human cancers including 
some carcinomas, melanomas, leukemias, and lymphomas (Arentson et al. 2002; Seo et 
al. 2005; Liontos et al. 2007).  Cdt1 overexpression alone in NIH3T3 cells can cause 
tumor formation in nude mice (Arentson et al. 2002). 
 Whereas Cdc6 has been proposed to function as an MCM  clamp loader (Perkins 
and Diffley 1998), the mechanisms by which Cdt1 promotes MCM loading are less clear. 
Unlike other components of the preRC, Cdt1 does not possess any known enzymatic 
motifs and its actual biochemical role in the loading of the MCM complex is unknown. 
Instead, Cdt1 seems to act as a scaffolding protein and its interactions with other proteins 
determine its physiologic roles (Sugimoto et al. 2008).  The work contained within this 
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dissertation describes a novel mechanism of Cdt1 function that  utilizes cell cycle time 
dependent interactions with specific enzymes to mediate the loading of MCMs. 
MCM Complex
 The MCM2-7 (mini-chromosome maintenance) family of proteins were grouped 
together based on sequence similarity and initially identified in genetic screens for 
mutations defective for plasmid maintenance or cell cycle progression (Dutta and Bell 
1997).  MCM deletion results in loss of cell viability  in S. cerevisiae and the loading of 
the Mcm2-7 complex onto chromatin represents the final step of preRC assembly (Hua 
and Newport 1998; Mendez and Stillman 2000).  The heterohexameric Mcm2-7 complex 
is thought to form a ring structure once loaded, with the DNA passing through the long, 
central channel (Remus et al. 2009).  
 The MCM complex is largely  believed to act as the replicative helicase, either 
alone or as a part of a larger complex with GINS and Cdc45, unwinding the DNA double 
helix allowing for DNA polymerase to gain access to its substrate and to accommodate 
replication fork progression (Chong et al. 2000; Sato et al. 2000; Shechter et al. 2000; 
You et al. 2002; Moyer et al. 2006) (Fig. 3).  All members of this heterohexamer are 
ATPases and members of the AAA+ family (Ying and Gautier 2005).  As discussed 
above, ORC, Cdc6, and Cdt1 are temporally  regulated to prevent improper loading of 
MCMs.  The MCM complex itself is also regulated in a cell cycle-dependent manner. 
MCMs can only associate with DNA in the absence of CDK activity, since CDK activity 
is required at the onset of S-phase, MCMs are prevented from re-associating with 
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chromatin after replication has begun (Hua et al. 1997).  The purpose of this research 
project was to elucidate a novel form of MCM  loading control that  involves the 
modulation of chromatin structure as a mechanism of replication licensing.
Pre-Replication Complex Quantification
 Little is known about mammalian preRC stoichiometry, the number of preRCs on 
chromosomes, and how this relates to replicon size and usage.  Our laboratory has found 
that, on average, each 100-kb of the mammalian genome contains a preRC composed of 
one ORC hexamer, 4-5 MCM hexamers, 2 Cdc6 proteins, and 0.35 Cdc45 proteins. 
Thus, based on ORC availability, mammalian cells, whose diploid genomes are 
approximately 7x109 bp, contain approximately 70,000 preRCs of this average total 
stoichiometry.  However, except for ORC, the chromatin-bound complement of preRC 
subunits is even lower.  
 Cdc45 is highly stable, and the same limited number of stable Cdc45 molecules 
are present from the beginning of S-phase to its completion.  Microinjection of excess 
purified Cdc45 into S-phase nuclei activates additional replicons by three-fold, indicating 
that Cdc45 functions to activate dormant preRCs and is rate-limiting for replicon usage 
and activation.  This low density  of preRCs, each containing only  a few MCMs that 
compete for limiting amounts of Cdc45, provides a molecular explanation why  somatic 
replicons are large in average size.  The stable, continuous, and rate-limiting nature of 
Cdc45 suggests that Cdc45 contributes to the staggering of replicon usage, and that 
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replicon activation requires reutilization of existing Cdc45 during S-phase (Wong et al. 
manuscript submitted 2010).  
Chromatin
Fig. 5 Structure of Chromatin.  Double stranded DNA does not and cannot  exist as a 
lone molecule within the cell, instead DNA is packaged within the nucleus by winding 
around a core histone octamer to form a nucleosome.  The nucleosomes are organized 
into higher-order chromatin structures, including a 30nm fiber “solenoid”.  
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 DNA does not exist within the nucleus as a naked molecule.  Instead, it is 
wrapped tightly around a positively charged histone core octamer that is comprised of 
two histone H2A/H2B dimers and a histone H3/H4 tetramer (Wolffe and Hayes 1999). 
This DNA-histone structure is known as a nucleosome, and represents the most basic unit 
of chromatin (de Ruijter et al. 2003) and are formed during DNA replication (Saha et al. 
2006).  Nucleosomes are connected with linker DNA of variable lengths, forming a 
beads-on-a-string structure, which organize into a more compact 30 nm fiber (Wu et al. 
2007).  30 nm fiber structures are further condensed into higher-order chromatin 
structures within the nucleus.  
 This packaging of DNA creates a physical barrier for processes that require DNA 
as a substrate, which leads to a fundamental accessibility  issue for proteins involved in 
transcription, DNA repair, and DNA replication (Demeret et  al. 2001).  Areas of the 
genome, known as euchromatin, are less tightly compacted, therefore these regions are 
more actively transcribed and replicate earlier in S-phase compared to condensed 
chromatin regions known as heterochromatin.  Thus, manipulation of chromatin structure 
represents an important level of spatio-temporal control for transcription and DNA 
replication (Demeret et al. 2001).  
 Two major classes of proteins are able to affect the condensation state of 
chromatin: ATP-dependent chromatin remodelers and histone modifying enzymes 
(Sengupta and Seto 2004).  ATP-dependent remodelers utilize the energy  of ATP to 
mediate chromatin remodeling by physically altering the position of nucleosomes on the 
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genome (Vignali et  al. 2000).  ATP-dependent remodelers are organized into five major 
families: SWI/SNF, ISWI, CHD, SWR1, and INO80 (Saha et al. 2006; Hayashi and 
Masukata 2010).  Post-translational covalent modification of core histones, to both tail 
and globular domain residues, and linker histone H1 are also an important mechanism to 
facilitate chromatin remodeling.  A diverse array of modifications, including acetylation, 
methylation, phosphorylation, ribosylation, and ubiquitination, can bring about changes 
in chromatin fluidity  either themselves by altering the histone-DNA interaction or by 
creating a pattern of modifications that are recognized by  downstream, effector proteins 
(Strahl and Allis 2000).  The recognition of one or more sequential modifications by 
effector proteins or protein complexes is known as the “histone code”. 
Histone Acetyltransferases
 An acetylation reaction describes the process of adding an acetyl group (-COCH3) 
to a molecule, which is catalyzed in biological systems by histone acetyltransferases, or 
HATs.  HATs, are divided into five large families: Gcn5-related acetyltransferases, 
MYST family  HATs, p300/CBP HATs, general transcription factor HATs, and the 
hormone receptor-related HATs (Carrozza et al. 2003b).  HATs often function as part of 
large, multi-subunit complexes that transfer acetyl groups onto lysine residues of histone 
tails and, though less frequently, histone globular domains.  
 Genomic regions containing acetylated histones are generally associated with 
increased transcriptional activity.  The widely accepted consequence of histone 
acetylation is the partial neutralization of the positive charge on histones, which in turn, 
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diminishes its association with negatively charged DNA, thus loosening the chromatin 
structure (Sengupta and Seto 2004).  Common acetylated residues associated with 
transcriptionally  active, open chromatin include acetylated histone H4K5, 8, 12, and 16, 
acetylated histone H3K9, 14, 18, and 23, acetylated histone H2AK5 and 9, and acetylated 
histone H2BK5, 12, 15, and 20 (Strahl and Allis 2000; Rice and Allis 2001).  Though this 
is not mutually exclusive of a role in the histone code mode of function for acetylation 
where acetylated lysine residues are recognized by downstream effectors, such as 
bromodomain containing proteins (Yang and Seto 2007).  
 In addition to effects on histones and chromatin structure, acetylation also 
represents an important post-translational modification for non-histone proteins (Glozak 
et al. 2005).  Reversible acetylation of non-histone proteins alters the electrostatic 
properties of the protein and can subsequently  influence protein stability, protein-protein 
interactions, protein localization, and DNA binding (Glozak et  al. 2005; Minucci and 
Pelicci 2006).  Therefore, reversible acetylation plays a role in a diverse array of cellular 
processes, including affecting proteins involved in gene expression, replication, DNA 
repair, translation, cell signaling, apoptosis, the cytoskeleton, and metabolism (Yang and 
Seto 2007).  Recently, global, high-resolution mass spectrometry analysis has 
demonstrated that the regulatory scope of the acetylome is comparable to the diverse 
spectra of protein phosphorylation (Choudhary et al. 2009). 
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HBO1
 HBO1 (histone acetyltransferase binding to ORC, also known as KAT7 or 
MYST2) is a MYST family  HAT that  was first identified by screening a HeLa cDNA 
library in a yeast two-hybrid system using human ORC1 as bait (Iizuka and Stillman 
1999).  The HBO1 HAT complex contains JADE1/2/3, Eaf6, and tumor suppressor 
proteins ING4/5.  JADE1 positively  influences the acetyltransferase activity of HBO1 
(Foy et al. 2008) and the PHD finger domains contained within the ING4/5 and JADE 
subunits influence HBO1 HAT complex targeting through preferential associations with 
methylated histone H3 (Saksouk et al. 2009).  
 HBO1 is primarily  responsible for the acetylation of lysines 5, 8, and 12 of 
histone H4 (Doyon et al. 2006) and plays a role in preRC licensing (Iizuka et al. 2006). 
Furthermore, HBO1 binds to mammalian origins through a physical interaction with Cdt1 
and acetylates histone H4 tails at origin regions during G1-phase, which is required for 
MCM  helicase recruitment  (Miotto and Struhl 2008; Miotto and Struhl 2010). 
Acetylation by HBO1 is also inhibited by  Geminin in a mechanism that  depends on 
binding to the HBO1-Cdt1 complex (Miotto and Struhl 2010).  p53 binds to HBO1 and 
inhibits its acetyltransferase activity and the subsequent MCM loading in response to 
certain cytotoxic shocks (Iizuka et al. 2008).  Interestingly, HBO1 has been found to be 
overexpressed in cancer cell lines and cancer tissues, which corresponds with its 
necessary  role in preRC licensing (Iizuka et al. 2009).  The work contained in this 
research project describes a mechanism by which Cdt1 acts to decondense chromatin to 
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facilitate MCM loading in a process that  requires histone H4 acetylation and is inhibited 
by coexpression of a catalytically-dead mutant of HBO1.
Histone Deacetylases
 Histone deacetylases (HDACs) catalyze the opposite reaction to HATs, namely 
the removal of the acetyl moiety  from ε-amino groups of lysine residues in both histone 
and non-histone proteins.  By opposing the reaction of HATs, HDACs inherently play a 
fundamental role in the many  biological processes that acetylation affects as described 
previously.  Since histone acetylation neutralizes that positive charge on the histone and 
decreases its affinity  with DNA, deacetylation has the converse effect and restores the 
positive charge on the histone, which results in a tighter, more compact chromatin 
structure (de Ruijter et  al. 2003; Sengupta and Seto 2004).  As shown in Figure 6, 
mammalian HDACs are organized into two major families and four subclasses based on 
their sequence homology to yeast counterparts and cofactor dependencies (Yang and Seto 
2007).  
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Fig. 6 Mammalian HDAC Family Organization.  
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Class I HDACs
 Mammalian class I HDACs show sequence homology to yeast RPD3, contain an 
N-terminal deacetylase domain and a C-terminal tail, and include HDAC1, HDAC2, 
HDAC3, and HDAC8 (Yang and Seto 2008).  Class I HDACs appear to be expressed in 
most cells and are almost exclusively  found in the nucleus (de Ruijter et al. 2003).  The 
conserved deacetylase core is shared by classical HDACs and encompasses 
approximately 390 amino acids.  Within this conserved deacetylase domain exists a tube-
like pocket that houses the zinc ion cofactor (Finnin et al. 1999).  The Zn2+ ion serves as a 
part of a charge-relay system that also utilizes adjacent histidine residues and two aspartic 
residues to catalyze the removal of acetyl groups (Finnin et al. 1999; de Ruijter et al. 
2003).  
 The classical HDACs are all inhibited by trichostatin A (TSA) and suberoyl 
anilide bishydroxamide (SAHA) that act by  inserting into the deacetylase pocket and 
forming a coordinate interaction with the Zn2+ ion and active site residues to impede the 
charge-relay  system (Finnin et al. 1999).  All class I members, with the exception of 
HDAC8, function within larger nuclear complexes that serve to repress transcription and 
modulate the epigenetic landscape.  For example, HDAC1 and HDAC2 are both found in 
Sin3, Mi-2/NuRD, and CoREST complexes and HDAC3 is a part of the N-CoR/SMRT 
complex, all of which act to silence transcription (Yang and Seto 2008). 
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Class II HDACs
 Class II HDACs show sequence homology  to yeast Hda1 and depend on Zn2+ ion 
as a cofactor for their deacetylase function.  Like class I HDACs, class II HDACs are 
inhibited by TSA and SAHA.  While class I HDACs are widely  expressed in mammalian 
cells, class II HDACs appear to be more restricted in terms of expression in different cell 
types, suggesting they may play  a role in differentiation and development (de Ruijter et 
al. 2003).  The class IIa members, comprised of HDAC4, HDAC5, HDAC7, and HDAC9 
all share a conserved, long N-terminal extension in addition to their similar deacetylase 
domains (Yang and Seto 2008).  
 Contained on these class IIa N-terminal extensions are binding sites for 14-3-3 
and myocyte enhancer factor 2 (MEF2) (de Ruijter et al. 2003).  The binding of these 
proteins to the class IIa HDACs affects their subcellular localization with MEF2 
promoting nuclear localization whereas 14-3-3 promotes cytoplasmic retention.  This 
dynamic nuclear/cytoplasmic transport of class IIa HDACs makes them unique signal 
transducers as they are actively shuttled in response to multiple cellular signals.  HDAC6, 
a class IIb HDAC, is unique in that  it is predominantly  cytoplasmic and contains two 
active deacetylase domains.  Given its subcellular localization, it serves as an important 
cytoplasmic, non-histone protein deacetylase and plays a role in a variety of cellular 
functions including cellular motility, cellular adhesion, activation of certain kinases, and 
regulating some immunologic functions (Yang and Seto 2008).  
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Class III HDACs
 Class III HDACs, termed Sirtuins, represent a distinct family from the classical 
HDACs and are homologous to the S. cerevisiae SIR2 (Silent Information Regulator 2). 
Seven human sirtuins, numbered Sirt1-7, have been identified to date and not all possess 
the ability to act as protein deacetylases, instead some act as mono-ADP 
ribosyltransferases.  Sirtuins differ from classical HDACs in terms of their enzymatic 
mechanism, subcellular localization, structure, sequence, and function (Michan and 
Sinclair 2007).  Instead of utilizing Zn2+ ion as a cofactor, Sirtuins employ NAD+ as a co-
substrate for the enzymatic removal of acetyl groups.  Sirt1, Sirt2, Sirt3, Sirt5, and Sirt6 
display  deacetylase activity, while Sirt4 possesses only  the ability to act as a 
ribosyltransferase.  Interestingly, Sirt2, Sirt3, and Sirt6 have the ability to catalyze both 
deacetylase reactions and ribosyltransferase reactions (Frye 1999; Liszt et al. 2005).  
 Since their mechanism of action is so different than the classical HDACs, it  is no 
surprise that TSA and SAHA are incapable of acting as inhibitors to the class III HDACs, 
instead sirtuins are inhibited by nicotinamide, a byproduct of their deacetylation reaction
(Landry  et al. 2000).  Sirt1, Sirt6, and Sirt7 reside predominantly in the nucleus, while the 
others are cytoplasmic proteins.  Interestingly, Sirt3, Sirt4, and Sirt5 reside in the 
mitochondria.  Sirtuins represent a relatively new area of HDAC research and many 
strides are being made to elucidate their impact on biological functions (Michan and 
Sinclair 2007). 
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Class IV HDAC: HDAC11
 Identified in 2002, HDAC11 is the lone member of the class IV HDAC grouping. 
HDAC11 possesses similarity  to class I HDACs and, to a lesser degree, class II HDACs, 
however its sequence similarity  was too low to designate it as a member of either class 
(Gao et al. 2002; de Ruijter et al. 2003).  HDAC11 does exhibit the qualities of a classical 
HDAC in that it requires Zn2+ ion as a cofactor for its deacetylase activity and is inhibited 
by TSA.  It is primarily localized to the nucleus, however it has been shown to co-
immunoprecipitate with the cytosolic HDAC6 protein (Gao et al. 2002).  HDAC11 is 
conserved from C. elegans, Drosophila, bacteria, plants, to humans (Yang and Seto 
2008).  This high level of evolutionary conservation suggests HDAC11 possesses an 
important function in a diverse range of organisms.  
 Expression of HDAC11 in Antigen Presenting Cells (APCs) functions to inhibit 
IL-10 expression and induced inflammatory APCs to prime naive T cells and restore the 
responsiveness of tolerant T helper cells (Villagra et al. 2009).  HDAC11 is highly 
expressed in murine brain cells (Liu et al. 2008) and seems to play a role in the regulation 
of oligodendrocyte-specific protein gene expression and oligodendrocyte development 
(Liu et al. 2009).  Recently, an S-phase, direct interaction between HDAC11 and Cdt1 has 
been identified (Glozak and Seto 2009).  Cdt1 was also found to be acetylated at its N-
terminus by the HATs PCAF and p300, and overexpression of HDAC11 correlated with 
reduction in acetylated Cdt1.  This reversible acetylation protects Cdt1 from 
ubiquitination and resulting proteasomal degradation, thus representing a potential 
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mechanism to regulate Cdt1 stability (Glozak and Seto 2009).  Due to its recent 
discovery, further biological roles of HDAC11 have yet to be fully elucidated, 
particularly with respect to regulation of DNA replication.  The research contained within 
this dissertation describes a novel role for HDAC11, in which it plays a role in regulating 
MCM loading by Cdt1 by manipulating chromatin structure.
Chromatin Remodeling in DNA Replication
 As described above, the condensation of the DNA substrate into nucleosomes and 
higher-order chromatin structures poses a fundamental problem for proteins and enzymes 
that require access to the DNA in order to function and represents an important regulatory 
component.  Although this issue of chromatin accessibility is a highly-studied topic in the 
field of transcriptional control (Wolffe and Hayes 1999; Hassan et al. 2001; Carrozza et 
al. 2003a), very little is known about how chromatin influences DNA replication, in terms 
of both initiation and elongation.  Just as in transcription, it is easily predicted that access 
to the DNA within the context of chromatin by the replication machinery  represents an 
important regulatory step.  In addition to creating access to DNA for preRC formation 
prior to S-phase, specific DNA-histone interactions need to be disrupted and recreated 
during the cell cycle to maintain faithful duplication of the genome and its chromatin 
structures (Falbo and Shen 2006).  
 Experiments in yeast, where ORC binding is more specific than higher 
eukaryotes, have demonstrated that nucleosomal positioning can affect ORC binding and 
preRC assembly (Falbo and Shen 2006; Hayashi and Masukata 2010).  When ARS DNA 
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is repositioned from an accessible area to one masked by a nucleosomal core particle, 
DNA replication is inhibited (Simpson 1990).   In support of this, replication origins, i.e. 
poly(dA-dT) regions, and ORC localization in S. cerevisiae yeast maps to nucleosome-
free regions using high-throughput sequencing (Eaton et al. 2010).  While similar 
genome-wide nucleosome positioning mapping in S. pombe resulted in differing 
nucleosome-depleted region patterns, nucleosome depletion was also detected over high 
efficiency origins la(Lantermann et al. 2010).  Interestingly, others have shown that 
nucleosomal positioning adjacent to ARS1 can enhance replication initiation, suggesting 
ORC binding and preRC formation efficiency  may be dependent on chromatin context 
(Lipford and Bell 2001).  Together, these data suggest nucleosomal positioning plays an 
important role in determining origin efficiency in eukaryotic cells.  
 It has previously been shown that, during replication fork elongation, Cdc45 
recruits Cdk2 to forks and leads to phosphorylation of the linker histone H1 (Alexandrow 
and Hamlin 2005).  This histone H1 phosphorylation causes higher-order chromatin 
structures to be opened and for fork progression to occur.  Significantly, such findings 
produced a novel explanation as to how the replication machinery is able to progress 
through higher-order chromatin, particularly  heterochromatic areas, which contain 
highly-condensed and largely inaccessible DNA.  
 With respect to chromatin remodeling at sites of replication initiation, initial 
studies have shown acetylation to be an important post-translational modification in 
determining origin fitness.  In yeast, deletion of the HDAC Rpd3 leads to overall genome 
replication initiating earlier in S-phase, as well as causing several normally late-firing 
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origins to fire earlier (Vogelauer et al. 2000; Vogelauer et al. 2002).  Conversely, targeting 
the Gcn5 HAT to a late-firing origin causes it to fire earlier than normally  observed in 
wild type cells (Vogelauer et al. 2000).  Very  similar results were obtained with an origin 
studied in Drosophila as Rpd3 deletion resulted in increased genomic replication 
(Aggarwal and Calvi 2004).  Targeting the Drosophila homolog of Rpd3 to a specific 
origin of the chorion locus reduced replicative activity, whereas targeting the Chameau 
acetyltransferase resulted in increased origin activity (Aggarwal and Calvi 2004). 
Furthermore, in mammalian cells, firing of the β-globin origin is influenced by local 
acetylation state (Goren et al. 2008).  Targeting of HATs to this region brings about a shift 
to earlier replication, that depends on the acetyltransferase activity as a CBP catalytically 
dead mutant did not  result in the same level of S-phase time reduction.  In contrast, 
targeting an HDAC to β-globin in erythroblasts, which normally replicate this region 
early in S-phase, results in a shift to late replication (Goren et al. 2008).  Consistent with 
this, HBO1 deletion inhibits preRC licensing and DNA replication as discussed above 
(Iizuka et al. 2006).  Together, these date describe a situation in which histone acetylation 
plays an important role in DNA replication initiation, however none full demonstrate a 
direct link between this acetylation event, chromatin remodeling, and DNA replication.  
34
Fig. 7 Acetylation Affects DNA Replication Initiation.  In yeast, global deletion of the 
HDAC Rpd3 results in earlier replication firing, while targeting the Gcn5 HAT results in 
earlier origin firing.  In flies, global disruption of Rpd3 resulted in increased replication. 
Targeting Rpd3 to a specific origin reduced replicative activity whereas tethering the 
Chameau acetyltransferase resulted in increased origin activity.  In mammalian cells, 
targeting a HAT stimulates earlier origin firing while targeting an HDAC causes delayed 
origin activity.  Global deletion of the HAT HBO1 also disrupts DNA replication and 
preRC licensing. 
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CHAPTER 2
MATERIALS AND METHODS
Cell Culture 
 CHO, A03_1, and HeLa cell lines were maintained in Minimum Essential 
Medium, MEM, (Cellgro) supplemented with 10% Fetal Clone II (HyClone) and 0.1% 
Gentamicin (Gibco).  HaCaT and 293T cell lines were maintained in Dulbecco’s 
Minimum Essential Medium, DMEM, (Cellgro) supplemented with 10% FBS (HyClone) 
and 0.1% Gentamicin (Gibco).  A03_1 cell medium also contained 0.3 µM methotrexate. 
Cells were synchronized by isoleucine deprivation (CHO) or serum deprivation (HaCaT) 
as described (Alexandrow and Hamlin 2005; Mukherjee et al. 2010).  Replicating DNA 
was labeled with 15 µM BrdU for 30 minutes at 37oC.  
Transfections
 Transfections were performed for 24 hours with FuGene-6 (Roche) or by 
treatment with polyethylenimine, PEI, as described (Reed et al. 2006).  Briefly, freeze-
thawed PEI reagent was diluted in 150 mM NaCl before plasmid DNA addition. 
Mixtures were vortexed and incubated at room temperature for 30 minutes before adding 
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directly  to cell media.  Initial transfection efficiencies were determined by transfection of 
Zsgreen plasmid for 24 hours and subsequent analysis by  fluorescent microscopy. 
Adenoviral infection assays were performed as described (Vaziri et al. 2003).  Colony 
forming assays used pTK-Hygro co-transfected and hygromycin selection (400 µg/ml).
Antibodies
 Anti-LacI (Stratagene or Upstate); anti-BrdU (Roche); anti-H1P (provided by C. 
Mizzen, University of Illinois); anti-HBO1 (provided by M. Smith, University  of 
Virginia); anti-Geminin, anti-Myc (S. Cruz Biotech); anti-HDAC11, anti-Flag, anti-actin 
(Sigma); anti-PCNA, anti-tubulin (Calbiochem); anti-HA (Covance); anti-Cdt1 (provided 
by H. Nishitani, Kyushu University, Japan); anti-Mcm2, anti-Mcm4, and anti-Mcm7 
were generated by Covance or Aves Labs.  Anti-mouse, anti-rabbit, and anti-chicken 
HRP-conjugated secondary antibodies (Jackson) were used.  Anti-mouse, anti-rabbit, and 
anti-chicken Texas Red or FITC-conjugated secondaries (Jackson) for 
immunofluorescence were used.  
Plasmids and cDNAs
 HsCdt1, HsGeminin, and pEBG-GST were provided by A. Dutta (University  of 
Virginia).  HsCdt1, CgCdc45, CgCdc6, BRCA1(6c-w mutant), HsHDAC1, and 
HsHDAC11 were expressed using pRcLac (Alexandrow and Hamlin 2005).  No NLS 
sequence was added to any  LacI construct.  LacI-VP16 was provided by A. Belmont 
(University  of Illinois).  HBO1-wt and HBO1-G485A were provided by M. Smith 
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(University  of Virginia).  Geminin, Cdc6, HBO1-wt, and HBO1-G485A were expressed 
from pcDNA3-HA, and HBO1-wt, HDAC1, and HDAC11 were expressed from 
pcDNA3-Flag.  Cdt1 was expressed using pcDNA3-6xMyc.  Set8-HBD was generated 
by proofreading PCR and expressed using pcDNA3-HA-NLS.
Protein Chemistry
 Immunoprecipitations (IP) were performed in TNN (50 mM Tris, pH7.4, 250 mM 
NaCl, 0.1% Igepal CA-630, and phosphatase and protease inhibitors).  Immune 
complexes were washed with lysis buffer 3X.  For immunoblots, equal numbers of cells 
were lysed and boiled in loading dye (for total lysates [TCE]) or were separated into 
detergent-resistant (chromatin) or detergent-soluble fractions as described (Mendez and 
Stillman 2000; Alexandrow and Hamlin 2005).  PreRC subunits present in the chromatin 
fraction are sensitive to nuclease digestion (Mendez and Stillman 2000).  TCE, soluble, 
and/or chromatin samples representing equivalent cell numbers were analyzed by 
standard immunoblotting and ECL.  Briefly, samples were loaded onto 10% SDS-PAGE 
gels and then transferred to Immobilon PVDF Transfer Membranes (Millipore) with 
subsequent probing with appropriate antibodies.  For gel filtration, Myc-Cdt1, Flag-
HDAC11 and HA-geminin were co-transfected into 293T cells using Lipofectamine 
2000.  Cells were collected and lysed with sonication in PBS lysis buffer containing 0.2% 
NP-40.  Lysates were purified over an anti-Flag column (Sigma).  Flag-HDAC11 and co-
purifying proteins were eluted using a Flag peptide (Sigma). Eluates were subjected to a 
size exclusion column (Superdex 200 HR 10/30 column, GE) using FPLC, and 0.3 mL 
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fractions were collected and analyzed by immunoblotting.
Immunofluorescence
 Cells were analyzed by IF and BrdU incorporation as described (Alexandrow and 
Hamlin 2005; Winter et al. 2009).  Briefly, cells grown on square microscope coverslips 
were rinsed 1x with RT PBS-pH7.4 and then fixed with either 2% formaldehyde (Fisher) 
for 15 minutes at room temperature or with 100% methanol (Fisher) for 5 minutes at 
-20oC.  Cells were then washed 2x with PBS-7.4 and then permeabilized with PBS-7.4 
containing 1% Normal Donkey Serum (NDS, from Jackson) and 0.2% Triton X-100 
(Promega), then washed 2x with PBS containing 1% NDS.  If replicating DNA was 
labelled with BrdU, DNA was then denatured with 1.5N HCl (in H2O) for 30 minutes at 
RT and washed with PBS-7.4.  Cells were then incubated for 1 hour at RT in a humidified 
chamber with the appropriate primary antibody dilution in PBS-7.4 with 1% NDS.  Cells 
were then washed 2x at RT with PBS-7.4 with 1% NDS.  Cells were then incubated again 
for 1 hour at RT in a humidified chamber with the appropriate fluorescent dye-conjugated 
secondary  antibody diluted in PBS-7.4 with 1%NDS.  Cells were then washed 2x at RT 
in PBS then stained for 5 minutes with 0.5 µg/mL DAPI (4',6-diamidino-2-phenylindole) 
and washed.  Coverslips were then mounted on slides using 50 µL of Prolong Antifade 
reagent (Molecular Probes).  Photographs of cells were obtained with a Zeiss Automated 
Upright Fluorescence Microscope in the Moffitt Cancer Center Analytic Microscopy 
Core, and images were merged using Adobe Photoshop. 
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Flow Cytometry
 For flow analysis of DNA re-replication, cells were trypsinized, washed with 
PBS-7.4, and then initially  fixed with 1% formaldehyde (Fisher).  Cells were then washed 
in PBS-7.4 and then fixed and stored in 70% ethanol (Fisher) at -20oC overnight.  After 
centrifugation to remove ethanol, cells were washed in PBS-7.4 and then resuspended in 
PBS-7.4 containing 30 µg/mL propidium iodide (PI), 0.1% Triton X-100, and 200 µg/mL 
RNase A.  Sample data were collected at the Moffitt Cancer Center Flow Cytometry  Core 
Facility  with a FACScan bench-top analyzer and data was analyzed using ModFit LT 
(VSH) and FlowJo software for percentage of cells containing greater than 4N DNA 
content. 
ChIP Assays and qPCR
 Synchronized HaCaT cells were fixed with 1% formaldehyde for 10 min at room 
temperature.  Crosslinked chromatin was sonicated in 10 mM  Tris-HCl (pH8), 1 mM 
EDTA, 0.5 mM EGTA, 1% SDS (plus phosphatase and protease inhibitors) to an average 
length of ~500 bp. Samples were adjusted to 5 mM Tris-HCl (pH8), 30 mM NaCl, 0.2% 
Triton X-100, 0.2% SDS, 0.8% BSA, 0.4 mM EDTA, 0.1 mM  EGTA, and chromatin 
from 5 x 106 cells was used for IP with anti-HDAC11 or control IgG (4oC overnight). 
Immune complexes were precipitated with anti-rabbit agarose, washed, and eluted in 10 
mM Tris-HCl (pH8), 1 mM  EDTA, 1% SDS at  65oC.  Crosslinks were reversed at 65oC 
overnight, and samples were treated with Proteinase K for 3 hr at 50oC.  Resulting DNA 
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was purified using phenol/chloroform extractions, and subjected to quantitative PCR 
(qPCR) in triplicate using a BioRad MyIQ detection system with TaqMan primers and 
FAM probes against previously described origin sequences (Ladenburger et al. 2002; 
Sibani et al. 2005).  Primers used were as follows: 
Lamin B2 origin probe: 5‘-TTAGACATCCGCTTCATTAGGGCAGAGG-3’
Lamin B2 origin forward: 5’-GCTACACTAGCCAGTGACCTT-3’
Lamin B2 origin reverse: 5’-GTTCTGCCTCTGAGTTTATTCCTG-3’
Lamin B2 exon probe: 5’-CTGAACTGGGATCTGACACCCACCA-3’
Lamin B2 exon forward: 5’-AGAAGAGACCAGGGTTCACAGA-3’
Lamin B2 exon reverse: 5’-GTGTTAACAGTCAGGCGCAT-3’
MCM4 origin probe: 5’-ACCCAAACTACCTCCGCAGGTCAGACGT-3’
MCM4 origin forward: 5’-TGGCCCGAATCAACATGGAA-3’
MCM4 origin reverse: 5’-AGCCAAGTCCAACACCAAGT-3’
MCM4 exon 9 probe: 5’-CCCACCGCAGCTCCCTACATTCCTT-3’
MCM4 exon 9 forward: 5’-TCCTCGACCCTGCTTTATGA-3’
MCM4 exon 9 reverse: 5’-TGCTGCAACAGACAGCAACA-3’
As previously  described (Birch et al. 2009), the enrichment of specific genomic DNA 
sequences was determined based on the threshold cycle (Ct) for each PCR product and 
analyzed according to the formula 2-Δ[Ct(IP)-Ct(input)]-2-Δ[Ct(control IgG)-Ct(input)]. Using this 
method, DNA relative to input and immunoprecipitated by anti-HDAC11 was normalized 
to DNA immunoprecipitated by control IgG. P values were obtained using the Student's 
two-tailed T-test.
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DNase I Accessibility Assays
 Chromatin was isolated in a buffer containing 10 mM Tris-HCl (pH7.5), 5 mM 
MgCl2, 1 mM CaCl2, 10 mM KCl, 300 mM sucrose and 0.1% Triton X-100 for 5 min on 
ice, then washed and resuspended with the same buffer lacking detergent. One third of 
the chromatin from a 10 cm plate of cells was digested with DNase I (Promega) at 3 
Units/100 µl for 10 min at RT. Another third was treated identically, but without DNase I 
(used for nomalization; untreated control). Reactions were stopped by  addition of 10 mM 
EDTA/2 mM EGTA and incubated at 65oC for 10 min. DNA was lightly  sonicated, then 
purified and analyzed using TaqMan-based qPCR as described for ChIP assays.
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CHAPTER 3
RESULTS
HDAC11 Associates with Replication Origins, Inhibits Cdt1-Induced 
Re-Replication, and Suppresses MCM Loading
 HBO1 interacts with Cdt1 at origins specifically during G1 and acetylates H4 
tails, which is required for MCM loading (Miotto and Struhl 2008; Miotto and Struhl 
2010).  The acetylation diminishes during S-phase, a time when MCM  loading is 
normally prevented (Miotto and Struhl 2010), suggesting that  a histone deacetylase may 
be involved in negatively regulating MCM loading.  HDAC11 interacts directly  with 
Cdt1 in S-phase (Glozak and Seto 2009) and can deacetylate H4 tails (Gao et al. 2002; 
Villagra et al. 2009), but is poorly understood in terms of its physiological function in 
cells.  As such, we asked if HDAC11 could bind to origins in S-phase and negatively 
influence MCM  loading and DNA replication.  Chromatin immunoprecipitation (ChIP) 
analyses performed on two origins previously  studied for HBO1 interactions (Miotto and 
Struhl 2008) demonstrated that HDAC11 becomes bound to MCM4 and Lamin B2 
origins in S-phase but  not in G1, whereas nearby  chromosomal regions show a small, but 
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non-significant increase in HDAC11 (Fig. 8).  Therefore, HDAC11 interacts with Cdt1 
and associates with chromosomal origins with the opposite kinetics of HBO1 (i.e., during 
S-phase), providing an explanation for why, in addition to reduced HBO1 activity, the H4 
acetylation diminishes during S-phase (Miotto and Struhl 2010).
Fig. 8 HDAC11 Chromatin Immunoprecipitation.  Synchronized HaCaT cells (as 
verified by BrdU incorporation and subsequent analysis by fluorescent microscopy, 
quantified results graphically  shown in top panel) were subjected to anti-HDAC11 ChIP 
and qPCR analysis at  the indicated time points to determine interactions to origin 
sequences (MCM4 Ori and Lamin Ori) and non-origin sequences (MCM4 exon 9 and 
Lamin exon).
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 Co-expression of HBO1 has been shown to enhance Cdt1-induced re-replication 
(Miotto and Struhl 2008).  Given that HDAC11 associates with Cdt1 and origins in S-
phase and our observation that HDAC11 overexpression in CHO by transient transfection 
suppresses BrdU incorporation compared to non-transfected cells (data not shown), we 
reasoned that HDAC11 might act in an opposite manner to HBO1 and suppress Cdt1-
induced re-replication.  Adenoviruses were used to overexpress Cdt1 (Vaziri et al. 2003) 
at three different levels, which produced a dose-dependent increase in the percentage of 
cells with >4N DNA content as determined by propidium iodide staining and subsequent 
FACS analysis (Fig. 9).  Overexpression of HDAC11 alone did not result in changes to 
the distribution of cells within the cell cycle (data not shown), but co-expression of 
HDAC11 with Cdt1 caused a significant reduction in the number of re-replicating cells 
(Fig. 10, top  panels).  Interestingly, expressing more Cdt1 diminishes the inhibitory 
effects of HDAC11 (Fig. 10, bottom panels).  This indicates that the suppression of DNA 
replication by HDAC11 is derived from a stoichiometric relationship that exists between 
the amount of Cdt1 and HDAC11 that is co-expressed.  Furthermore, these results 
suggest that the inhibitory effect of HDAC11 is not due to an unrelated block to cell cycle 
progression into S-phase.  Higher levels of Cdt1 overexpression not only  increases the 
proportion of cells exhibiting >4N DNA content, but also appears to shift the distribution 
of cells within the cell cycle resulting in a diminished G1 population of cells, but an 
increased number of cells in S and G2-phases (Fig. 9).  This may be caused by 
subpopulations of cells that have re-replicated only  parts of their genome, but have not 
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accumulated enough re-replication to be detected by this FACS procedure.  Staining by 
PI measures DNA content  within a cell and this procedure is only  able to detect re-
replication in the subpopulation of cells that accumulates in the >4N DNA FACS 
population, which ignores lesser levels of re-replication that have not  generated sufficient 
PI staining (Dorn et al. 2009).  To circumvent this underestimation of re-replication 
levels, future experiments to analyze Cdt1-induced re-replication and suppression by 
HDAC11 could utilize the more sensitive single molecule DNA fiber analysis, or fiber 
spreading method.  Analysis of re-replication using this technique will allow for the 
measurement of re-replication at the single replication fork level, which could more 
accurately provide physiologically relevant data regarding generation of re-replication 
events and the suppression of such events (Dorn et al. 2009).  
 Overexpression of HDAC11 alone suppresses the loading of Mcm2 on chromatin 
(Fig. 11), but has no affect on the total levels of Mcm2 or Cdt1.  These results 
demonstrate that HDAC11 localizes to chromosomal origins in S-phase and inhibits the 
ability  of Cdt1 to promote DNA replication and MCM loading.  As such, and given the 
positive role of HBO1 in these processes during G1 (Iizuka et al. 2008; Miotto and Struhl 
2008), HDAC11 temporally opposes the function of HBO1 in regulating replication 
licensing via Cdt1 interactions in S-phase.
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Fig. 9 Cdt1 Overexpression Causes Re-Replication.  HeLa cells were infected for 48 
hours with increasing amounts of adenovirus expressing Cdt1.  Samples were processed 
for flow cytometric analysis and data was analyzed with FlowJo software.  Relative 
amounts of each virus used to infect cells are shown and percentages indicate proportion 
of cells with >4N DNA content. 
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Fig. 10 HDAC11 Suppresses Cdt1-Induced Re-Replication.  HeLa cells were infected 
for 48 hours with increasing amounts of adenovirus expressing Cdt1 or Cdt1 and 
HDAC11.  Samples were processed for flow cytometric analysis and data was analyzed 
with FlowJo software.  Relative amounts of each virus used to infect cells are shown and 
percentages indicate proportion of cells with >4N DNA content.
48
Fig. 11 HDAC11 Overexpression Inhibits MCM Binding to Chromatin.  HeLa cells 
were infected for 24 hours with adenovirus expressing HDAC11 or control GFP.  Cells 
were harvested and separated into soluble and chromatin-bound fractions.  Immunoblots 
were performed with indicated antibodies.
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Geminin Facilitates the Binding of HDAC11 to Cdt1
The ability of HDAC11 to bind to Cdt1, negatively influence MCM  loading, and 
suppress DNA replication is similar to the biological effects of Geminin (Wohlschlegel et 
al. 2000; Saxena et al. 2004).  This suggested a relationship might exist between Geminin 
and HDAC11 in regulating Cdt1 function.  We obtained an anti-HDAC11 antibody that 
recognizes two isoforms of HDAC11, indicated here as bands A&B (Fig. 12 and 13).  
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Fig. 12 Verification of anti-HDAC11 Antibody.  CHO cells were transfected with LacI-
HDAC1 or LacI-HDAC11 (left panel).  The left panel immunoblot demonstrates the 
recognition of an endogenous HDAC11 doublet, denoted as band A and band B and the 
specific recognition of an overexpressed LacI-HDAC11 fusion protein with shifted 
molecular weight, but not a LacI-HDAC1 fusion protein.  The right panel shows IP-
Western analysis of CHO cells transfected with Flag-HDAC1 or Flag-HDAC11.  Lysates 
were subjected to anti-Flag IP then anti-HDAC11 IB.  
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Using synchronized cell lysates separated into soluble and chromatin bound 
fractions, we observed that Geminin and the faster migrating band B of HDAC11 become 
chromatin bound with similar kinetics specifically  during S-phase, both of which parallel 
PCNA binding kinetics (Fig. 13).  The slower migrating band A of HDAC11 increases 
only modestly on chromatin during S-phase.  In contrast, HBO1 associates with 
chromatin earlier in G1 and peaks during the time of MCM  loading (6-12 hrs), consistent 
with the positive role HBO1 enzymatic activity  plays in promoting licensing during G1 
(Iizuka et  al. 2006; Miotto and Struhl 2008; Miotto and Struhl 2010).  Cdt1 is chromatin-
bound throughout G1 and S-phase, but a slower migrating form (asterisk) becomes 
visible that overlaps MCM  loading kinetics (Fig. 13). The slower migrating Cdt1 is likely 
to be a ubiquitinylated form of Cdt1 that is known to be degraded (Arias and Walter 
2005).  Consistent with this, the slower migrating Cdt1 diminishes after its initial 
appearance.  The kinetics for HBO1 and HDAC11 are graphed in Figure 14.  These 
results are consistent with a model in which HBO1 promotes licensing in G1 and 
HDAC11 prevents re-licensing during S-phase, in both cases through association with 
Cdt1.
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Fig. 13 Chromatin Binding Kinetics of HDAC11.  Synchronized CHO cells were 
separated into soluble and chromatin-bound fractions at the indicated times and subjected 
to IB with indicated antibodies.  BrdU verified synchrony (data not shown).
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Fig. 14 Graphical Representation of HDAC11 Chromatin Binding Kinetics.
  Although Geminin negatively influences the acetyltransferase activity of HBO1, 
it does not affect the physical interaction of HBO1 with Cdt1 (Miotto and Struhl 2008). 
Given the similar chromatin binding kinetics between Geminin and HDAC11, we next 
determined if Geminin influenced the interaction of HDAC11 with Cdt1.  Geminin and 
HDAC11 can independently bind Cdt1 in vivo and in vitro (Saxena et  al. 2004; Glozak 
and Seto 2009), indicating that neither protein requires the other to directly bind Cdt1. 
HDAC11, Geminin, and Cdt1 were transiently expressed in several combinations, and 
immunoprecipitations (IP) were performed against HDAC11 or Cdt1, followed by 
immunoblotting (IB) for the presence of the other expressed proteins in the IP complexes. 
Without  Geminin, HDAC11 and Cdt1 interact to a small degree when either protein is 
pulled down in the IP step (Fig. 15, lane 5, rows A&C).  Similarly, Geminin can bind 
Cdt1 in the absence of HDAC11 (Fig. 15, lane 6, row D).  However, when all three 
proteins are co-expressed, there is a noticeable increase in the amount of HDAC11 that 
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interacts with Cdt1, when either Cdt1 or HDAC11 is pulled down in the IP step (Fig. 15, 
compare lanes 5&8 on rows A&C).  The amount of Geminin that interacts with Cdt1 is 
not influenced by HDAC11, indicating that the converse is not true (Fig. 15, compare 
lanes 6&8, row D).  These results demonstrate that Geminin increases the efficiency of 
the HDAC11-Cdt1 interaction.
 We next asked if Geminin, HDAC11, and Cdt1 could form a trimeric complex in 
cells, or coexist together in a larger, multi-protein complex.  Cdt1, Geminin, and 
HDAC11 were co-expressed and complexes containing Flag-HDAC11 were purified and 
separated by  a size-exclusion column.  All three proteins co-elute in an ~700 kDa size 
range (Fig. 16 fractions 15&16).  Such an elution profile could be due to two separate, 
but similarly-sized, large complexes in which HDAC11 is present with Geminin in one 
and with Cdt1 in the other.  However, this is highly  unlikely given that Geminin and Cdt1 
interact efficiently in cells on their own (Wohlschlegel et al. 2000; Saxena et al. 2004). 
Therefore, these results indicate that all three proteins reside together in one complex 
(that contains other unknown proteins), which is consistent with the fact that HDAC11 
and Geminin both associate with Cdt1 in vivo during S-phase under physiologic 
conditions (Wohlschlegel et al. 2000; Glozak and Seto 2009).  Since Geminin and 
HDAC11 do not reduce the efficiency with which either protein can bind Cdt1 (Fig. 15), 
Geminin and HDAC11 do not compete for binding to Cdt1 and can interact with Cdt1 
simultaneously.  These results suggest that one function of Geminin in negatively 
regulating DNA replication may derive from an inherent ability  of Geminin to facilitate 
HDAC11 binding to Cdt1, leading to decreased MCM loading.
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Fig. 15 Geminin Enhances the Cdt1-HDAC11 Interaction.  Indicated proteins (top) 
were expressed in 293T cells and subjected to immunoprecipitation (IP) and 
immunoblotting (IB) analysis as indicated on right.  IP and IB analyses were performed 
with anti-tag antibodies.  Representative of three separate experiments with similar 
results.
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Fig. 16 Geminin, HDAC11, and Cdt1 Interact in a Single Complex.  Flag-HDAC11, 
HA-Geminin, and Myc-Cdt1 were co-expressed in 293T cells followed by anti-Flag 
purification.  Eluates containing Flag-HDAC11 complexes were separated on a size 
exclusion column and analyzed by IB. 
Cdt1 Targeting Induces Large-Scale Chromatin Decondensation
Cdt1 recruits two histone modifying enzymes, HBO1 and HDAC11, that  regulate 
MCM  loading and DNA replication in an opposing manner.  The timing of the 
association of these enzymes with replication origins coincides with the presence or 
absence, respectively, of acetylated histone H4 (Miotto and Struhl 2010).  Although the 
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H4 acetylation is known to be required for MCM recruitment (Miotto and Struhl 2010), 
the mechanism by which it facilitates this is unknown.  We hypothesized that the ability 
of Cdt1 to differentially recruit these enzymes produced higher-order chromatin structural 
changes that facilitate or inhibit  MCM  recruitment via altered chromatin accessibility. 
Currently, there is no technological means to assess changes to higher-order chromatin 
structure at chromosomal origins.  However, to test this concept, we employed an 
innovative chromatin remodeling system that assesses the ability  of proteins to generate 
changes to higher-order chromatin structure (Tumbar et al. 1999; Alexandrow and 
Hamlin 2005).  This system utilizes a CHO-derived cell line (A03_1) that contains a 90 
Mb homogeneous staining region (HSR) that was engineered through stable insertion and 
amplification of a Lac-operator(LacO)/DHFR vector (final HSR contains ~1600 such 
vectors).  The presence of LacO sites throughout the HSR allows for microscopic 
visualization of chromatin structural changes that occur following targeting of LacI-fused 
proteins of interest (Fig. 17).  In its normal unperturbed state, the HSR adopts a 
condensed dot-like structure that is heterochromatic in nature (Li et al. 1998).  However, 
targeting proteins that recruit chromatin remodeling enzymes elicits dramatic changes in 
the HSR structure, resulting in clearly  observable, highly decondensed HSRs occupying 
large portions of the nucleus (Tumbar et al. 1999; Alexandrow and Hamlin 2005).  This 
system provides insight into regulation of higher-order chromatin dynamics that cannot 
be analyzed by any other current experimental means.
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Fig. 17 Schematic of in vivo Chromatin Remodeling System.
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The mechanisms underlying chromatin remodeling in this system derive from 
specific, physiologically  relevant events involved in altering chromatin structure by 
targeted proteins.  Several transcription factors, including p53, E2F1, BRCA1, VP16, and 
ER, promote decondensation via histone acetylation, H2AX phosphorylation, and 
recruitment of chromatin modifying enzymes (Tumbar et al. 1999; Ye et al. 2001; Nye et 
al. 2002).  The replication protein, Cdc45, promotes decondensation via Cdk2 recruitment 
and H1 phosphorylation(Alexandrow and Hamlin 2005).  In contrast, some proteins 
promote condensation (Verschure et al. 2005), while others produce no changes to the 
HSR structure (remains condensed).  
Fig. 18 VP16 induces chromatin remodeling, but Cdc6 and LacI do not.  LacI-VP16, 
LacI alone, or LacI-Cdc6 were transiently  expressed in A03_1 cells, followed by IF with 
anti-LacI and Texas Red to detect open/decondensed (‘O’) or closed/condensed (‘C’) 
HSRs.  Nuclei were stained with DAPI. 
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 To determine if Cdt1 can promote large-scale decondensation of the HSR, Cdt1 
was fused to LacI and transfected into A03_1 cells.  As controls, LacI-VP16, LacI-Cdc6, 
or the LacI DNA binding domain (DBD) alone were also expressed.  Figure 18 shows 
that LacI-VP16 promotes large-scale decondensation, while LacI-Cdc6 and LacI-DBD do 
not, consistent with previous findings (Tumbar et al. 1999; Alexandrow and Hamlin 
2005).  Targeting Cdt1 to the HSRs produces a dramatic decondensation of the chromatin 
(Fig. 19).  
Fig. 19 Cdt1 Induces Chromatin Remodeling.  LacI-Cdt1 was transiently expressed in 
A03_1 cells, followed by  IF with anti-LacI and Texas Red to detect open/decondensed 
(‘O’) or closed/condensed (‘C’) HSRs.  Nuclei were stained with DAPI.
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 All proteins express similarly  (Fig. 20), and the fact that LacI alone expresses 
significantly higher indicates that targeting proteins does not  itself elicit changes to the 
HSR due to crowding or related effects.  As described previously (Alexandrow and 
Hamlin 2005), we assigned 'open' versus 'closed' status to the visual appearance of the 
HSRs using objective criteria.  Open structures clearly display large, decondensed HSRs 
that occupy more than 10% of the nuclear area.  Closed HSRs are obvious condensed 
structures that failed to unfold and typically cover less than 5% of the nuclear area.  In all 
analyses, some HSRs are visible that are dot-like in appearance, but somewhat larger in 
size (~5-10% of nuclear area).  We refer to the latter as Indeterminate, since classifying 
such HSRs is highly subjective.  Using these objective criteria, ~2/3 of LacI-Cdt1 
targeted HSRs become decondensed, similar to that for VP16 (Table I).  In addition to 
being enriched at the HSRs due to LacI targeting, the LacI-Cdt1 protein is also localized 
throughout the nucleus and not in the cytoplasm (Fig. 21), demonstrating that the 
localization of ectopic Cdt1 is regulated by physiologic mechanisms.  We conclude from 
these results that targeting Cdt1, but not Cdc6, to chromosomal regions in vivo produces a 
clearly observable and robust decondensation of higher-order chromatin structure.
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Fig. 20 Expression Levels of LacI-Fusion Proteins.  Immunoblot  of LacI-fusion protein 
expression for the results in Table 1.  
Fig. 21 LacI-Cdt1 Localizes to the Nucleus.  Anti-LacI immunofluorescence separated 
from DAPI showing LacI-Cdt1 present throughout the nucleus.
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Cdt1-Induced Chromatin Unfolding Occurs During G1
 We reasoned that, if chromatin unfolding induced by Cdt1 were physiologically 
involved in creating chromatin access for loading MCMs, then such unfolding should 
occur during G1.  We determined the cell cycle phase at the time when decondensation 
occurred after LacI-Cdt1 targeting.  To indicate S-phase cells, BrdU staining was used, 
and cells that were in G2 and/or M-phases were identified by anti-H1-phospho (H1-P) 
staining, since H1-P levels are highest at  these times (Lu et al. 1994; Alexandrow and 
Hamlin 2005).  LacI-Cdt1-induced open HSRs were found almost exclusively  in 
transfected cells that neither displayed BrdU nor H1-P staining (Fig. 22).  These results 
indicate that the cells are primarily in G1 (but early S-phase is also possible) at the same 
time that the transient LacI-Cdt1 protein is expressed and open HSRs are being 
generated.  Interestingly, closed HSRs correlated in the opposite manner (i.e., with S, G2, 
or M-phase cells).  Thus, chromatin unfolding by Cdt1 occurs in G1, when Cdt1 is known 
to function in MCM loading.
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Fig. 22 Cdt1-Induced Chromatin Decondensation Occurs in G1-phase.  LacI-Cdt1 
was expressed in A03_1 cells for 24 hours, then pulsed with BrdU.  Anti-BrdU and anti-
H1-P staining was used to relate the index of BrdU-negative and H1-P-positive cells to 
the open or closed HSR status.
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Geminin Efficiently and Specifically Suppresses 
Cdt1-Induced Chromatin Unfolding
 Since Geminin is a physiologic inhibitor of Cdt1 at high Geminin:Cdt1 ratios 
(Lutzmann et al. 2006), we asked if the decondensation by  Cdt1 were Geminin sensitive. 
Chromatin decondensation assays were performed using a 1:1 ratio of Geminin:Cdt1 
vectors, or a higher 5:1 ratio.  Relative protein expression is shown in Figure 23. 
Fig. 23 Expression Levels of LacI-Cdt1 and HA-Geminin.  HA-Geminin was 
transfected to a 5:1 or 1:1 plasmid ratio with LacI-Cdt1 and relative protein expression 
was verified by IB.
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 Compared to LacI-Cdt1 + pcDNA3 control, 1:1 ratios of Geminin:Cdt1 did not 
alter the amount of decondensation produced by Cdt1 (Table I).  However, co-expression 
of Geminin at a 5:1 ratio significantly  suppressed the ability of Cdt1 to decondense 
chromatin (Table I and Fig. 24, top panels).  Under these conditions, we noticed the 
appearance of a number of very small, but slightly decondensed HSRs, which we define 
as 'small-open' (Fig. 24, top left panel).  We considered these ‘small-open’ HSRs as 
closed, since they have clearly not succeeded in becoming large decondensed HSRs that 
are normally  seen with Cdt1 expressed alone (compare Fig. 24, top panels vs. bottom 
panels).  Chromatin unfolding induced by  Cdc45 or VP16 was not sensitive to inhibition 
by Geminin (Table I), indicating that the inhibitory effect of Geminin toward Cdt1 is 
specific and is not due to global effects that suppress chromatin remodeling mechanisms. 
These results demonstrate a novel effect of Geminin in modulating chromatin 
accessibility through its interaction with Cdt1.
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Fig. 24 Geminin Inhibits Cdt1-Induced Chromatin Unfolding.  Examples of small-
open and closed HSRs resulting from transfection of a 5:1 plasmid ratio of HA-
Geminin:LacI-Cdt1.
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Chromatin Unfolding by Cdt1 is Required for Cell Proliferation 
and Efficient DNA Re-Replication
 We next determined the region within Cdt1 that is required for promoting 
chromatin unfolding, and then tested for biological effects of loss of this domain. 
Carboxy-terminal truncations of Cdt1 were generated and tested for chromatin unfolding 
ability, and it was found that a region in the middle of Cdt1 is required for chromatin 
decondensation.  A deletion mutant of Cdt1 was made that lacked specifically this region 
(Fig. 25) and was deficient for chromatin unfolding (Fig. 26).  
Fig. 25 Deletion Mutant of Cdt1 that is Defective for Chromatin Remodeling. 
Diagram showing location of Cdt1 chromatin remodeling domain.
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Fig. 26 Cdt1 Deletion Mutant Does Not 
Cause Chromatin Unfolding.  Chromatin 
unfolding ability of Cdt1-(Δ201-355) was 
tested.  LacI-Cdt1-(Δ201-355) was expressed 
in A03_1 cells for 24 hours before analysis.
 Stable expression of Cdt1-(Δ201-355) was found to significantly  inhibit the 
ability  of cells to proliferate relative to wt-Cdt1 (Fig. 27).  Intriguingly, a previous report 
analyzing Cdt1 mutant alleles found that Cdt1 lacking this region is 25-60% less efficient 
at promoting re-replication versus multiple Cdt1 alleles that contain this region (Teer and 
Dutta 2008).  In agreement with this prior study, Cdt1-(Δ201-355) is 25-50% reduced in 
re-replication ability versus wt-Cdt1 (Fig. 28).  The reason Cdt1 re-replication is not 
completely diminished is because all alleles containing the amino-terminus of Cdt1 will 
induce re-replication due to dilution of Cdt1 degradation machinery by competitive 
binding, allowing endogenous Cdt1 to induce re-replication in addition to the exogenous 
protein being tested (Teer and Dutta 2008).  As such, we conclude from these 
experiments that the chromatin unfolding function of Cdt1 is required for sustained cell 
cycle progression due at least in part to a necessity for this region to promote efficient 
DNA replication.
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Fig. 27 Cdt1 Deletion Mutant Inhibits Cell Survival.  Colony forming assays were 
performed in CHO cells to test the ability of wt-Cdt1 and Cdt1-(Δ201-355) to suppress 
colony  growth.  Stable selection for protein expression lasted 14 days, followed by 
Giemsa staining.  
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Fig. 28 Cdt1 Deletion Mutant is Inhibited in Causing Re-Replication.  HeLa cells 
were used as in Figure 8 to determine the re-replication induction ability of Cdt1-
(Δ201-355) compared to wt-Cdt1, except 48 hour transfections were used.  Results from 
two experiments are shown, compared to wt-Cdt1 normalized to 100% re-replication 
ability.
Chromatin Decondensation by Cdt1 Stimulates MCM Recruitment
 We next asked if chromatin decondensation by Cdt1 stimulated the recruitment of 
endogenous MCMs.  Chromatin unfolding assays were performed in which LacI-Cdt1 
was expressed, followed by co-staining against LacI (to identify  open or closed HSRs) 
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and Mcm4 or Mcm7.  Figure 29 shows that endogenous Mcm4 and Mcm7 both become 
noticeably enriched at Cdt1-decondensed HSRs.  In contrast, HSRs decondensed by 
BRCA1 or VP16 did not enhance Mcm7 recruitment (Fig. 30).  We also found that 
PCNA became enriched at  Cdt1-decondensed HSRs (Fig. 31), but the effect was not 
dramatic and only occurred in a small percentage of such samples (<10%, data not 
shown).
Fig. 29 Cdt1-Induced Chromatin Unfolding Stimulates MCM Recruitment.  Open 
HSRs following LacI-Cdt1 expression were co-stained by  IF with antibodies to LacI, 
Mcm7, or Mcm4.  Arrows indicate open HSRs and enrichment of endogenous MCMs. 
A03_1 cells were used and transfections lasted 24 hours. 
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 Relative to BRCA1 and VP16, where MCM  co-localization was far less frequent 
and not dependent on chromatin decondensation, ~1/3 of Cdt1-decondensed HSRs 
displayed enriched MCM  recruitment (Fig. 30).  Only  a small number (5%) of Cdt1-
bound HSRs that failed to open recruited MCMs.  This result was obtained in more than 
6 separate experiments (data not shown, but see below).  This consistent observation 
probably  derives from our necessary use of asynchronous populations for these analyses. 
The machinery involved in MCM loading is only available during a certain period of time 
in the cell cycle, and in cells released from quiescence, MCM  loading occurs in the latter 
~1/3 of G1 (Mukherjee et al. 2009).  Cdt1-induced decondensation occurs in G1 (Fig. 22) 
and MCM recruitment is seen in only ~1/3 of these, which correlates with such a 
prediction.
 A simple explanation for why MCMs are enriched at  the HSRs upon Cdt1 
targeting could derive from the fact that Cdt1 can bind to MCMs (Tanaka and Diffley 
2002; Yanagi et al. 2002; Teer and Dutta 2008).  However, Cdt1-bound HSRs that fail to 
open are not efficiently enriched with MCMs (Fig. 32), indicating that  the presence of 
Cdt1 alone at these chromosomal sites is not sufficient for MCM  recruitment.  Since a 
significant number of Cdt1-decondensed HSRs are not  enriched for MCMs, the 
recruitment of MCMs does not itself produce a crowding effect that causes the unfolding. 
We conclude from these results that  Cdt1-induced decondensation is a prerequisite for 
stimulating MCM recruitment.
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Fig. 30 BRCA1 and VP16 Chromatin Remodeling Does Not Recruit Endogenous 
MCMs.  Open HSRs following LacI-BRCA1 or LacI-VP16 expression were co-stained 
by IF with antibodies to LacI or Mcm7.  Arrows indicate open HSRs and enrichment of 
endogenous MCMs.  A03_1 cells were used and transfections lasted 24 hours. 
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Fig. 31 PCNA can be Recruited to Chromatin 
Unfolded by Cdt1.  Open HSRs following LacI-
Cdt1 expression were co-stained by  IF with 
antibodies to LacI and PCNA.  Arrows indicate open 
HSRs and enrichment of endogenous PCNA.  A03_1 
cells were used and transfections lasted 24 hours. 
Fig. 32 Quantification of 
E n d o g e n o u s M c m 7 
Recruitment.  This graph 
depicts the proportion of 
HSRs that demonstrated 
c o l o c a l i z a t i o n w i t h 
endogenous Mcm7 as a 
result of LacI-Cdt1, LacI-
BRCA1, or LacI-VP16 
targeting.
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HBO1 and HDAC11 Regulate Cdt1-Induced Chromatin Unfolding
 Given that HBO1 and HDAC11 are known histone/chromatin modifiers (Gao et 
al. 2002; Doyon et al. 2006), we asked whether these factors could modulate Cdt1-
induced chromatin decondensation.  We verified that HDAC11 and Cdt1 interact in vivo 
in reciprocal co-IP experiments (Fig. 33, left).  Similarly, HBO1 and Cdt1 interact in vivo 
(Fig. 33, right).  
Fig. 33 Cdt1 Interacts with HDAC11 and HBO1 in vivo.  IP-Western assays were 
performed using the indicated proteins and anti-tag antibodies.  293T cells were used and 
transfections lasted 24 hours. 
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 LacI-Cdt1 was co-expressed with HDAC1, HDAC11, HBO1-wt, or HBO1G485A 
(catalytically-inactive), and the decondensation potential of Cdt1 was determined for 
each condition.  Similar amounts of LacI-Cdt1 expression were achieved, but more LacI-
Cdt1 was expressed with HBO1G485A (Fig. 34).  Similar expression of HDAC1 and 
HDAC11 was achieved, while HBO1G485A expressed slightly less well compared to 
HBO1-wt.  
Fig. 34 Expression Levels of LacI-Cdt1 with Flag-HDAC1, Flag-HDAC11, HA-
HBO1-wt, and HA-HBO1-Mutant.  Immunoblot of indicated proteins showing their 
relative protein expression for the results in Table 2 and 3.  
78
HDAC1 and HBO1-wt do not alter the ability  of Cdt1 to induce chromatin unfolding 
(Table II).  However, HDAC11 dramatically  suppresses the ability  of Cdt1 to cause 
decondensation, producing a concomitant increase in closed HSRs.  Despite being 
expressed at lower levels relative to HBO1-wt, and in the presence of higher amounts of 
LacI-Cdt1, HBO1G485A also suppresses Cdt1-induced decondensation.  In comparison, 
HDAC1, HDAC11, HBO1-wt, and HBO1G485A do not affect VP16-induced 
decondensation (Table II).  We conclude from these results that HBO1 normally  performs 
a positive role specifically  in Cdt1-induced chromatin unfolding, while HDAC11 is a 
strong and specific inhibitor of the decondensation by Cdt1.  Furthermore, these results 
indicate that the effects of HBO1 and HDAC11 on chromatin remodeling by Cdt1 are not 
due to global cellular changes that affect chromatin remodeling in general.
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HBO1 and HDAC11 Influence MCM Recruitment to Cdt1-Targeted HSRs
 We next  asked if HBO1 or HDAC11 influenced the level of MCM  recruitment to 
Cdt1-targeted HSRs.  Chromatin remodeling assays were performed as above, but co-
stained and quantified for enrichment of endogenous Mcm4 or Mcm7.  HDAC1 and 
HBO1-wt again had no effect  on the ability of Cdt1 to cause chromatin decondensation 
(data not shown), nor did either protein significantly alter the amount of Mcm4 or Mcm7 
that was enriched overall (Fig. 35 and Table III).  In both cases, MCM  enrichment was 
primarily  associated with HSRs that had undergone a decondensation event  (Fig. 35).  In 
contrast, HDAC11 and HBO1G485A again inhibited the ability of Cdt1 to cause 
decondensation (producing closed HSRs; data not shown), and this was associated with a 
significant reduction in total MCM enrichment (Fig. 35 and Table III).  For both 
HDAC11 and HBO1G485A, any enrichment of MCMs was almost exclusively  associated 
with the small percentage of HSRs that had unfolded under these conditions (data not 
shown).  We conclude from these results that HBO1 is normally  required for efficient 
chromatin unfolding and MCM recruitment by Cdt1, while HDAC11 is a potent and 
specific inhibitor of the ability of Cdt1 to cause decondensation and MCM recruitment.
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Fig. 35 HDAC11 and HBO1-Mutant Inhibit Cdt1-Induced Chromatin Unfolding 
and Subsequent Endogenous MCM Recruitment.  Examples of co-localizing Mcm7 
(or lack thereof) in cells expressing indicated combination of proteins.  Samples were 
processed by IF with indicated antibodies as in Figure 29.  Open/decondensed (‘O’), 
closed/condensed (‘C’) HSRs.  Quantitative results are presented in Table 3.
Chromatin Decondensation and MCM Recruitment by 
Cdt1 Involve Histone H4 Acetylation
 Recruitment of MCMs to chromosomal origins depends on HBO1 
acetyltransferase activity toward histone H4 (Miotto and Struhl 2010).  We reasoned that 
histone H4 modifications played a role in the Cdt1-induced decondensation and MCM 
recruitment to the HSRs due to the involvement of HBO1 and HDAC11 in this process. 
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Although we predicted that  H4 acetylation on residues K5, K8, or K12 should be 
increased at the decondensed HSRs following Cdt1 targeting, we observed no stable 
association of such modifications with the unfolded HSRs (data not shown).  H4 
acetylation is known to be a transient event at origins (Miotto and Struhl 2010), which 
likely explains our inability to observe stable H4 modifications.  However, to show that 
H4 acetylation does play a functional role in the decondensation process, we took 
advantage of the ability  of the Set8 histone methylase H4 binding domain (HBD) to 
interact with H4 tails and block their acetylation (Yin et al. 2008; Miotto and Struhl 
2010).  
Fig. 36 Expression of Flag-
HDAC1 and Flag-Set8-HBD. 
Anti-Flag immunoblot showing 
the relative transient expression 
of Flag-HDAC1 versus Flag-
Set8-HBD.  Panels are from the 
same immunoblot/exposure.  
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 Set8-HBD, HDAC1, or GST was co-expressed with LacI-Cdt1, and the ability of 
Cdt1 to promote chromatin decondensation and MCM recruitment was determined.  As 
described above, HDAC1 does not  affect  the ability of Cdt1 to unfold chromatin and 
promote MCM  recruitment.  However, although Set8-HBD expresses less efficiently than 
HDAC1 (Fig. 36), co-expression of Set8-HBD significantly reduces the ability  of Cdt1 to 
promote decondensation relative to HDAC1 (Figs. 35&37 and Table II).  Co-expression 
of GST similarly has no effect on Cdt1-induced chromatin unfolding (Fig. 37 and Table 
II) and MCM recruitment (Fig. 37 and Table III).  These results strongly suggest that, at 
least in a transient manner, acetylation of H4 tails is necessary for Cdt1 to induce 
chromatin unfolding and stimulate MCM  recruitment in vivo.  These findings are 
consistent with prior studies showing that HBO1 catalytic activity and the resultant H4 
acetylation at origins are required for MCM  recruitment by  Cdt1 (Miotto and Struhl 
2010), but now provide mechanistic evidence that such H4 acetylation promotes 
chromatin accessibility and fluidity that facilitates the loading of the MCM  complex. 
Intriguingly, the amount of suppression elicited by Set8-HBD is very  similar to that 
caused by HBO1G485A (Table II), as expected if H4 acetylation by HBO1 plays a 
functional role in Cdt1-induced chromatin unfolding.  However, neither Set8-HBD nor 
HBO1G485A are as potent as HDAC11 at  suppressing Cdt1-induced unfolding, suggesting 
that additional modifications, perhaps on other histone subunits, are likely involved in 
this process.
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Fig. 37 Blocking Histone H4 Acetylation Prevents Cdt1-Induced Chromatin 
Decondensation and Endogenous MCM Recruitment.  Examples of co-localizing 
Mcm4 (or lack thereof) in A03_1 cells expressing indicated proteins.  Open/decondensed 
(‘O’), closed/condensed (‘C’) HSRs.  Quantitative results are presented in Table 3.  
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Chromatin at Endogenous Origins of DNA Replication
is More Accessible during G1 versus S-phase
 Our results suggest that chromatin at origins of DNA replication will be more 
accessible in G1 when MCMs are loading, due to Cdt1 and HBO1 activities, but less 
accessible during S-phase, due to HDAC11 recruitment by  Cdt1.  Intriguingly, at least 
three reports in the literature have shown this situation to be true at higher eukaryotic 
origins.  The chromatin at the GAS41 origin in chicken cells and the β-globin origin in 
human cells displays increased DNase I hypersensitivity  during G1, but becomes less 
accessible to nuclease digestion in S-phase (Djeliova et al. 2002; Zimmermann et al. 
2007).  Similarly, chromatin at the ori-β and ori-γ origins in CHO cells is more accessible 
and sensitive to micrococcal nuclease in G1 versus S-phase (Pemov et al. 1998).  
 We determined if the same were true at  the MCM4 and Lamin B2 origins in 
human cells.  HaCaT cells were synchronized and released into the cell cycle, and intact 
chromatin was isolated in late-G1 and S-phase and subjected to controlled DNase I 
digestion followed by qPCR analysis (Fig. 38).  Less accessible chromatin at these 
origins reduces DNase I digestion, resulting in more substrate available for qPCR. 
Relative to late-G1, the MCM4 and Lamin B2 origins are both less accessible to DNase I 
in S-phase as indicated by  the increased qPCR substrate availability  from these time 
points.  Thus, six higher eukaryotic endogenous replication origins analyzed by different 
methods (indirect end labeling or qPCR) display increased chromatin accessibility in G1, 
but less accessibility during S-phase.  Our results now provide a molecular explanation 
for this differential chromatin accessibility  at replication origins that involves Cdt1-
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modulated control over higher-order chromatin structure via temporal recruitment of 
HBO1 and HDAC11.
Fig. 38 Chromatin at Endogenous DNA Replication Origins is More Accessible 
During G1-phase than in S-phase.  HaCaT cells were synchronized by serum 
deprivation and verified by BrdU incorporation as in Figure 8.  qPCR was performed on 
DNase I treated chromatin samples from the indicated time points.  Results were 
normalized against input chromatin from each time point that was not treated with DNase 
I, to account for increases in DNA levels during S-phase.  Assays were performed in 
triplicate to generate error bars.  
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CHAPTER 4
DISCUSSION AND FUTURE DIRECTIONS
Cdt1-Induced Chromatin Decondensation Mediates MCM Loading
 We present evidence for a novel form of replication licensing control that involves 
the ability of Cdt1 to modulate chromatin accessibility through the temporal recruitment 
of HBO1 and HDAC11 (modeled in Fig. 39).  In G1, Cdt1 (by  ORC interaction) recruits 
HBO1 to replication origins, resulting in acetylation of H4 within the origin regions 
(Miotto and Struhl 2008; Miotto and Struhl 2010).  We show here that at least one effect 
of this acetylation is an increase in chromatin accessibility that is required for MCM 
recruitment.  HBO1 catalytic activity is required for MCM loading at origins (Miotto and 
Struhl 2010), and HBO1 stimulates Cdt1-dependent re-replication (Miotto and Struhl 
2008).  Upon entering S-phase, de novo MCM  recruitment is blocked, and we show here 
that HDAC11 contributes to this process. HDAC11 interacts with Cdt1 and localizes to 
replication origins specifically in S-phase, and HDAC11 is capable of catalyzing the 
removal of acetylation from H4 (Gao et al. 2002).  Consistent with this, H4 acetylation 
decreases at replication origins during S-phase (Miotto and Struhl 2010).  HDAC11 
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potently inhibits the ability of Cdt1 to cause chromatin decondensation, suppresses the 
recruitment of MCMs, and blocks Cdt1-induced re-replication.  As such, HDAC11 
directly  opposes the functions of Cdt1 and HBO1 in promoting replication licensing, 
thereby producing a ‘yin-yang’ relationship  between HBO1 and HDAC11.  The 
mechanism underlying this relationship derives from the ability of HBO1 to promote 
chromatin decondensation for MCM loading in G1, followed by  the recruitment  of 
HDAC11 in S-phase, which produces chromatin inaccessibility and prevents MCM 
loading.  Such a model is supported by temporal changes in chromatin accessibility at 
endogenous origins in higher eukaryotic cells shown here and by others (Pemov et al. 
1998; Djeliova et al. 2002; Zimmermann et al. 2007), where origins are more accessible 
in G1 and transition to less accessible chromatin organization in S-phase.
 Geminin is a physiologic inhibitor of Cdt1 during S-phase (Wohlschlegel et al. 
2000).  While the binding of Geminin to Cdt1 reduces the ability of Cdt1 to interact with 
the MCM  complex (Yanagi et al. 2002; Cook et al. 2004), Geminin has been found to 
also influence the function of HBO1 in association with Cdt1.  Geminin does not  alter the 
interaction of HBO1 with Cdt1 (Miotto and Struhl 2008), but instead inhibits the 
acetyltransferase activity of HBO1 (Miotto and Struhl 2010).  We present evidence here 
that another mechanism whereby Geminin modulates Cdt1 function is through enhanced 
HDAC11 recruitment to Cdt1 (modeled in Fig. 39).  Thus, Geminin indirectly suppresses 
H4 acetylation at origins by  inhibiting HBO1 acetyltransferase activity  and by  promoting 
the recruitment of HDAC11.  As a result, Geminin produces decreased chromatin 
accessibility that blocks MCM loading, which is supported by our observation that 
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Geminin potently and specifically suppresses chromatin decondensation induced by  Cdt1. 
Fig. 39 Working Model. 
91
Currently, we do not know how Geminin modulates HBO1 HAT activity  or HDAC11 
association with Cdt1.  One possibility  is that Geminin directly  influences HBO1 activity 
and interactions of HDAC11 with Cdt1, although Geminin does not compete with either 
protein for Cdt1 binding.  However, an alternative explanation may  derive from Geminin-
regulated recruitment of unknown factors that themselves control these events.  Clearly, 
further investigation is required to answer these questions.
 There is currently no technological means to observe large-scale chromatin 
structural changes at specific single genomic loci in mammalian cells (i.e., origins). 
Although we have utilized an innovative, but engineered, chromatin remodeling system 
to address this question, several lines of evidence indicate that the events observed using 
this system recapitulate those occurring at origins, but at a macroscopic level.  Chromatin 
decondensation induced by Cdt1 occurs during G1 and is sensitive to Geminin in a highly 
specific manner.  Cdt1-induced decondensation involves H4 acetylation during the 
process of unfolding, is dependent on HBO1 function, and is sensitive to HDAC11 
inhibition.  In both cases, these enzymes elicit  their effects specifically  for chromatin 
decondensation derived from Cdt1.  MCM  recruitment is clearly  observed as a specific 
result of Cdt1-induced decondensation, and is inhibited by mutant HBO1 and HDAC11 
in a specific manner.  As described above, Cdt1, HBO1, and H4 acetylation dependency 
for MCM recruitment is also true at origins specifically  during G1.  HDAC11 associates 
with origins during S-phase (and not  in G1), when H4 acetylation decreases and origin 
access would be predicted to be blocked, and HDAC11 reduces Cdt1-induced re-
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replication potential and suppresses genomic MCM  loading.  Most importantly, and 
highly  consistent with our findings, endogenous DNA replication origins display 
temporal changes in chromatin organization that produce more open and accessible 
conditions during G1, but transition to a less accessible chromatin state in S-phase 
(results herein, and references (Pemov et al. 1998; Djeliova et  al. 2002; Zimmermann et 
al. 2007).  Collectively, such results provide a strong argument that our observations in 
vivo at this engineered locus represent physiologic events occurring during replication 
licensing that cannot be seen by any  other current experimental approach.  Importantly, 
these results indicate that chromatin accessibility is at  least one mechanism whereby 
Cdt1, HBO1, HDAC11, and Geminin regulate replication origins via H4 acetylation 
changes.
Chromatin Remodeling in DNA Replication
 In yeast and flies, the HBO1 homologs GCN5 and Chameau, respectively, induce 
acetylation of histones globally  and near origins, which promotes origin firing (Vogelauer 
et al. 2002; Aggarwal and Calvi 2004).  In contrast, Rpd3, which is homologous to 
HDAC11, decreases acetylation and reduces origin activity (Vogelauer et al. 2002; 
Aggarwal and Calvi 2004).  Similarly, the timing of activation of the β-globin origin in 
mammalian cells is influenced by its acetylation state. Whereas acetylation of the β-
globin is associated with earlier firing, targeting HDAC2, which is related to HDAC11, 
renders the origin late-firing (Goren et al. 2008).  Our results provide a mechanistic 
explanation for these studies of replication origin control by histone acetylation in which 
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the acetylation influences chromatin accessibility  for MCM  loading.  Although we do not 
know biochemically how H4 acetylation promotes chromatin unfolding, at least two 
possibilities are likely.  First, histone H4 acetylation has been shown to directly enhance 
chromatin accessibility via structural changes (Shogren-Knaak et al. 2006), consistent 
with what we have observed herein. Second, histone acetylation may recruit 
bromodomain containing proteins that facilitate the chromatin unfolding (Strahl and Allis 
2000).  Neither of these mechanisms is mutually exclusive with the other and it is 
possible both may contribute to chromatin structural changes at origins.  Finally, it is 
likely that chromatin modifying enzymes other than HBO1 and HDAC11 are involved in 
regulating replication origins. For example, SNF2H and WSTF have been shown to co-
purify with Cdt1 and differentially bind to chromatin depending on histone tail 
modifications (Hakimi et al. 2002; Sugimoto et al. 2008).
 
Cdt1 and Cancer
 Cdt1 is oncogenic and overexpressed, sometimes via amplification, in several 
human cancers, including lung and colon carcinomas, melanomas, and some leukemias 
and lymphomas (Arentson et al. 2002; Seo et al. 2005; Liontos et al. 2007). 
Overexpression of Cdt1 alone in NIH3T3 fibroblasts leads to the formation of tumors in 
Rag2 null mice (Arentson et al. 2002).  Furthermore, the T-cell-directed overexpression 
of Cdt1 in the absence of p53 in transgenic mice leads to the development of 
lymphoblastic lymphoma, further demonstrating the impact of deregulated Cdt1 in 
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contributing to tumorigenecity  (Seo et al. 2005).  These observations indicate that 
increased Cdt1 expression and deregulation of preRC licensing can lead to tumorigenesis.
 A normal cell cycle involves a single round of DNA replication, and the 
oncogenic nature of Cdt1 derives from its ability to promote MCM  loading and re-
replication, the result of which is an increase in genomic instability  (Vaziri et al. 2003; 
Liontos et al. 2007).  Decreasing levels of Geminin, a biological inhibitor of Cdt1, also 
results in re-replication, suggesting the functional balance of preRC components is 
important in preventing over-replication of the genome (Saxena and Dutta 2005).  The 
acute overexpression of Cdt1 and Cdc6 leads to re-replication and DNA damage, most 
notably double strand breaks, which initially result in senescence and apoptosis (Liontos 
et al. 2007).  However, prolonged growth stimulus by  Cdt1 and Cdc6 eventually 
overcomes these antitumor barriers and the induced re-replication leads to recombination 
and genomic instability that selects for cell populations with aggressive phenotypes 
(Liontos et al. 2007).   Chromosomal analysis of tumor cells resulting from Cdt1 
overexpression in NIH3T3 cells demonstrated a multitude of chromosomal abnormalities 
including chromosome breaks and gaps, polyploidy, and chromosome end associations 
(Seo et al. 2005).  Furthermore, increased Cdt1 and Cdc6 expression in a subset of mantle 
cell lymphomas was highly associated with the formation of secondary chromosomal 
abnormalities compared to MCL populations without an unbalanced increase in DNA 
replication licensing proteins (Pinyol et  al. 2006).  These findings demonstrate that Cdt1 
deregulation result in re-replication and subsequent loss of genome integrity, which 
correlate with tumorigenesis.
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  The genetic instability  caused by Cdt1-induced re-replication results in the 
transformation of a cell by disrupting the normal context of chromosomal regulation of 
genes responsible for growth control, apoptosis, and metastasis.  A diverse array of 
genetic alterations can potentially  lead to changes in expression of such proteins that are 
involved in oncogenesis.  Aneuploidy, which results in large changes in genetic material 
by gains or losses of entire chromosomes or chromosomal domains, is one such result of 
genomic instability.  The loss of large genomic regions could result in the deletion of 
tumor suppressor proteins, while chromosomal duplication has the potential to increase 
gene dosage of oncogenes (Lengauer et  al. 1998; van Gent et al. 2001).  Re-replication 
can also lead to the amplification of specific genomic regions, potentially resulting in the 
onion-skin model of amplification (Bostock 1986).  The result  of this type of re-
replication is increased gene copy number, which would have an impact in the 
tumorigenic potential of a cell if oncogenes were amplified (Green et al. 2010).  Other 
ramifications of these re-replication events include DNA damage and double strand 
breakage, which can perpetuate genomic instability (Green and Li 2005).  Errors in 
double stranded break repair, normally  performed by non-allelic homologous 
recombination and non-homologous end joining, can lead to compromised genetic 
stability  culminating in loss or gains of genomic material and potentially chromosomal 
translocations (Ferguson et al. 2000; Ferguson and Alt 2001; Khanna and Jackson 2001). 
Translocations represent gross genomic alterations that can potentially give rise to 
tumorigenesis (Ferguson and Alt 2001).  In this process, chromosomes are rearranged, 
whereby large chromosomal regions are exchanged and fused, which can deregulate 
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oncogenes or tumor suppressors and cause transformation (Lengauer et  al. 1998; van 
Gent et al. 2001)
 Our results suggest that one molecular mechanism mediating Cdt1’s ability to 
promote re-replication is the temporal recruitment of histone modifying enzymes that 
alter chromatin structure and thereby modulate chromatin accessibility.  Excessive levels 
of Cdt1 will inappropriately cause chromatin decondensation cycles at origins, allowing 
re-loading of MCMs within one cell cycle.  The resultant  re-initiation of DNA replication 
within S-phase produces genomic instability, and as such, provides a novel molecular 
explanation for how tumorigenesis can occur due to changes in chromatin accessibility at 
replication origins. This model of deregulated chromatin access is supported by the 
findings that the expression of the histone acetyltransferase, HBO1, is elevated in several 
human carcinomas (Iizuka et al. 2009).
 Since the overexpression of licensing factors, in particular Cdt1, can lead to 
oncogenic transformation, an important question then arises with respect to HDAC11 and 
its potential role as a tumor suppressor.  Since we have demonstrated that HDAC11 is 
recruited to replication origins in S-phase and acts to inhibit Cdt1 function, it stands to 
reason that disruption of HDAC11 expression or function would lead to Cdt1-induced re-
replication and subsequent genomic instability.  To test this hypothesis, acute knockdown 
of HDAC11 protein levels by RNAi (or the utilization of a catalytically-dead HDAC11 
mutant) would be useful to assess its ability  to regulate the re-replication caused by Cdt1 
as determined by FACS or single molecule DNA fiber analysis.  Stable knockdown of 
HDAC11, for example by shRNA or generation of a HDAC11 null mouse, would also 
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provide great insight into its ability  to act as a tumor suppressor.  One may expect  that 
such cells lacking HDAC11 could be more prone to tumorigenesis.  Long-term 
suppression of HDAC11 expression could potentially lead to cytogenetically abnormal 
cells harboring chromosomal aberrations reflective of long-lived genomic instability, 
which would be identified by FISH analysis.  Furthermore, such stable knockdowns 
could also be analyzed by the single molecule DNA fiber analysis to measure low level 
re-replication.  Since Cdt1 is regulated, both in terms of function and stability, by 
multiple mechanisms in addition to HDAC11, it is possible that HDAC11 impairment 
alone would not cause re-replication as the redundancy in Cdt1 regulation would be 
sufficient in preventing this.  To this end, it  would be beneficial to analyze HDAC11 
knockdowns with respect to their tolerance of Cdt1 overexpression when compared with 
control, normal HDAC11 cells.  For example, HDAC11 null cells may be more 
susceptible to Cdt1-induced re-replication than normal cells.  Moreover, since Cdt1 
overexpression in NIH3T3 cells and p53 null transgenic mice lead to tumorigenesis 
(Arentson et al. 2002; Seo et  al. 2005), and we observe that HDAC11 inhibits Cdt1-
induced re-replication, co-overexpression of HDAC11 with Cdt1 in the NIH3T3 cells or 
transgenic mouse model system may be inhibited in tumor formation.  It would be of 
great interest to pursue these investigations to determine if HDAC11 can indeed function 
as a tumor suppressor.
 Two mechanisms of cell cycle arrest previously thought to be independent, were 
recently  shown to be causally related.  Replicative stresses and their resultant genomic 
instability trigger DNA damage responses and cell cycle senescence via ATM and Chk2 
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(Gorgoulis et al. 2005; Liontos et al. 2007), while oncogene activation leads to oncogene-
induced senescence through p16INK4A and ARF (Braig and Schmitt  2006).  Instead of 
being distinct mechanisms, two groups recently found that oncogene-induced senescence 
utilizes DNA damage repair mechanisms to elicit senescence in addition to p16INK4A and 
ARF (Bartkova et al. 2006; Di Micco et al. 2006).  These reports demonstrate that the 
expression of activated oncogenes results in senescence that is dependent on both DNA 
replication and DNA damage repair, and that inhibition of these processes inhibits the 
observed oncogene-induced senescence.  The expression of oncogenic Ras was shown to 
directly  lead to hyper-replication and increased replicon activation (Di Micco et al. 2006) 
while the expression of other oncogenes, including mos, cdc6, and cycline E led to 
senescence dependent on functioning DNA damage repair machinery, which is normally 
activated as a consequence of double strand breaks reflective of re-replication and 
genomic instability (Bartkova et  al. 2006).  Together, these findings suggest that 
oncogene overexpression induces re-replication and genomic instability.  Such a result 
could be due to increased preRC component expression as well as increased licensing of 
preRCs.  Furthermore, several histone modifying enzymes have been shown to be 
upregulated as a result of oncogene overexpression, which could lead to aberrant 
chromatin access being granted and subsequent, improper MCM loading and preRC re-
licensing as we have shown chromatin fluidity to be a likely regulator of preRC 
assembly.  Activated Ras has been associated with increased Gcn5 and PCAF histone 
acetyltransferase expression that is associated with the epithelial-mesenchymal transition 
in carcinoma cells (Pelaez et al. 2010), while increased Her2 oncogene expression in 
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certain breast cancer cells is associated with an increased copy number of the HBO1 gene 
(Hu et al. 2009).  
 If the induction of the DNA damage repair pathway  observed with oncogene 
overexpression is indeed dependent on re-replication resulting from the generation of 
improper chromatin access and preRC assembly, modulation of chromatin modifying 
enzymes could result in inhibition or exacerbation of senescence.  Reduction of proteins 
that facilitate the creation of chromatin access, such as HATs, could potentially abrogate 
the hyper-replication and senescence that accompanies activated Ras expression.  For 
example, acute downregulation of HBO1 by RNAi along with Ras overexpression may 
diminish the observed hyper-replication by DNA combing and senescence by  SA-β-gal 
staining compared to when control RNAi is used with Ras.  Conversely, overexpression 
of HBO1 with Ras could lead to increased levels of hyper-replication and increased 
number of senescent cells.  Furthermore, overexpression of HDAC11 with activated Ras 
may serve to prevent or inhibit hyper-replication and subsequent induction of senescence. 
Undertaking such experimental procedures that serve to correlate chromatin access with 
oncogene-induced hyper-replication would add further support to the model in which we 
propose chromatin fluidity as a mechanism of replication licensing.  
Future Directions
 The findings described here define a novel form of replication licensing involving 
the generation of chromatin access by Cdt1 to facilitate MCM loading.  This control is 
mediated by two Cdt1-interacting enzymes: HBO1 and HDAC11.  The mechanisms of 
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control elucidated in this research project establish a new paradigm for Cdt1 function, but 
many questions must still be answered in order to develop a thorough understanding of 
this chromatin decondensation-based licensing mechanism.  For instance, though HBO1 
and HDAC11 are integral players in this Cdt1 driven chromatin remodeling, are other 
histone modifying enzymes or ATP-dependent chromatin remodelers involved?  By what 
mechanisms does Geminin affect the Cdt1-HDAC11 interaction?  What  domains of Cdt1 
are responsible for HDAC11 and HBO1 interaction?  What effect does HDAC11 
disruption have on replication?  Further investigation is required to elucidate a more 
complete and fluid comprehension of this novel mode of licensing.
Cdt1-Induced Remodeling and Histone Modifications
 We have shown that histone H4 acetylation plays a role in Cdt1-mediated 
chromatin decondensation (Fig. 37).  While intriguing, it  is unlikely that H4 acetylation is 
the only modification on which chromatin remodeling at origins and MCM  loading is 
based.  Interestingly, we have found that a small proportion of Cdt1 opened HSRs 
colocalizes with dimethylated histone H3 lysine 9.  This finding is important as it 
suggests other histone modifications and other enzymes are likely involved in the 
remodeling.  Furthermore, the methylation state of histone H3 is known to influence 
HBO1 HAT complex binding, though not through H3K9 (Saksouk et al. 2009).  To 
further our understanding of the histone modification status of Cdt1-induced remodeling, 
we propose to utilize a broader panel of antibodies to modified histones to analyze in 
conjunction with HSR decondensation.  
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Fig. 40 Cdt1-Induced Remodeling Colocalizes with Methylated Histones.  A03_1 
cells were transfected with LacI-Cdt1 or LacI-VP16 and co-stained for anti-LacI or 
endogenous anti-diMethyl histone H3 lysine 9.  Arrows indicate location of HSR. 
*denotes a modified histone ring circumscribing the HSR for this example.  
   
 
 In order to identify novel Cdt1-binding proteins, Sugimoto et  al. performed a 
large-scale Cdt1-complex purification by affinity  chromatography and liquid 
chromatography, followed by tandem mass spectrometry analysis (Sugimoto et al. 2008).  
To identify other proteins modulating Cdt1-induced chromatin remodeling, it may be 
prudent to perform such large-scale Cdt1 protein purifications in synchronized cell 
populations, as other labs have found important  Cdt1 interactions to be cell cycle-
dependent (Miotto and Struhl 2008; Glozak and Seto 2009).  As such, Cdt1 purifications 
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in asynchronous populations may result in the dilution of important binding partners with 
more short-lived interactions.  Such a pursuit could serve to dissect out separate Cdt1-
containing complexes that  exist during preRC licensing (i.e. G1) and after MCM loading 
is actively suppressed (i.e. S-phase).  This investigation has the potential to uncover other 
chromatin modifying enzymes (i.e. histone methyltransferases, other HATs, etc.) or ATP-
dependent remodelers as active players in preRC licensing.
Cdt1 and Geminin-HDAC11
 We have demonstrated that Cdt1, Geminin, and HDAC11 exist  in a single, large 
complex (Fig. 16) and that Geminin enhances the Cdt1-HDAC11 interaction (Fig. 15). 
To further investigate the role of each protein in the dynamics of a large, multi-subunit 
complex in vivo, we propose to utilize the Bimolecular Fluorescence Complementation 
system (Hu et al. 2002), which involves tagging a protein of interest with half of the 
enhanced yellow fluorescent protein (EYFP) and tagging a potential binding partner with 
the other half of EYFP.  Upon co-transfection, stably interacting proteins will bring the 
two half tags within close proximity, thereby recapitulating the full length EYFP protein, 
resulting in yellow fluorescence detectable by microscopy.  We have generated functional 
parental vectors based on this system and have demonstrated effective fluorescence 
complementation between Cdt1 and Geminin (Fig. 41).  
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Fig. 41 Bimolecular Fluorescence 
Complementation between Cdt1 
and Geminin.  CHO cells transfected 
with both Cdt1 and Geminin, each 
fused with a half YFP tag generates 
fluorescence (top  panels).  CHO cells 
transfected with only Cdt1 with its 
half tag or Geminin with its half tag 
do not emit light (bottom panels).  
We propose to clone HDAC11 into the BiFC vector complementary  to Cdt1 to determine 
if this protein pair can generate successful complementation in this system, and the 
subcellular localization of this association.  BiFC interactions between Cdt1-Geminin and 
Cdt1-HDAC11 can then be used to determine if titration of overexpressed HDAC11 or 
overexpressed Geminin, respectively, have any effect in modulating the fluorescent 
complementations, either in intensity or localization.  
 To further assess Geminin’s role in Cdt1-induced chromatin remodeling, we 
propose to utilize a series of Geminin mutants (Fig. 42).  As previously  reported (Saxena 
et al. 2004), several Geminin mutants have been analyzed in terms of their ability  to 
homodimerize, bind Cdt1, and block replication, however the ability of these mutants to 
disrupt Cdt1-induced chromatin remodeling has yet to be investigated.  We intend to co-
??????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????? ??????????????????????????????? ?????????? ????????????become 
chromatin-bound during the time interval of 6-12 hrs, which is also the interval of accumulation for Cdc6 and 
????????????????? ?????????????????????????? ???????????????????????????????? ??????????????????????????????????
????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????
??????????? ?? ????????????? ???????????? ??????????????? ?????????????? ???? ???? ???????????? ????????? ?? ????????
??? ????????????????? ???????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????? ?????????????????????????? ???????
MCM loading, but then not being necessary on chromatin after the MCMs have loaded. Interestingly, the band 
??????????????? ????????????????????????????????????????????????????? ???????????and? ???????????????????????
where it is seen that accumulation begins slightly at 9 hrs and continues increasing up to the last time point of 
??????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
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?????????? ????????????? ?????????? ???????????????????????????????????????? ???????????????
????? ??????????????????????? ???????????????????????????? ??????????enzymatic activity also 
increases during G1 when MCMs load (45).
HBO1, like Cdt1, is required for MCM loading and S-phase entry, and HDAC11 
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???????????????????????????????? ??????????????????????? ??????????????????????????
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?????????????????????????????????Xenopus system (45) (but was not tested in mammalian 
????????????????? ??? ????????? ???????????????????????? ????????????? ??????????????????????
phase entry. These results are entirely consistent with our hypothesis and preliminary data 
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Establishment of Bimolecular Fluorescent Complementation 
between Geminin and Cdt1
? ????????????????????in vivo Geminin-Cdt1 interactions as they pertain 
??????????????????????????????????? ??????????????????????????????in vivo 
protein-protein interaction technique established in the Kerppola laboratory 
????? ???? ???? ??????? ?????? ? ????????? ???????????? ???????????????
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the two proteins can interact in vivo, then yellow light will be generated 
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Fos was deleted (41). The system recapitulates published information 
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transfect each mutant in a titratable manner to test their ability  to affect chromatin 
unfolding by Cdt1.  Furthermore, we propose to determine each mutant’s ability to 
modulate the Cdt1-HDAC11 interaction by performing co-IPs and utilizing the BiFC 
system as described above.  Utilizing the mutants along with the BiFC system will 
provide a clearer understanding of Geminin’s ability  to enhance the Cdt1-HDAC11 
interaction.  Perhaps Geminin serves as a molecular switch at the onset of S-phase when 
the Geminin:Cdt1 ratio increases (Lutzmann et al. 2006), which could potentially trigger 
HDAC11 and Cdt1 to bind.
??????????????????????????????? ?????????????????????????????? ??????? ?????????????????closure of the chromatin 
to prevent further MCM loading. We will address this idea in more detail here, with a particular emphasis on 
?????????????????????????? ????????????????????????????????????????????????????????????????????????????????
defective in various ways. Results from these studies will allow us to determine if a correlation exists between 
the abilities of these Geminin mutants to bind Cdt1, their abilities to block S-phase, and their abilities to block 
chromatin remodeling by Cdt1. We further hypothesize that Geminin may modulate the interactions of Cdt1 with 
the two remodeling enzymes, HBO1 and HDAC11, and that this may explain how Gemi in works to control Cdt1 
?????????? ?????????????????????????????????????????????????????????????????? ??????????????????????????????? ?????
???????????? ????????? ?????????????????????? ??????????????????????????????????????????????????
???????????????? ???????????????????????????????????
?????? ????????????????????? ??????? ??????????????????? ??????????????????????????????????????
??????????????? ?????????????????????????? ?????????????????????????????
 In order for Geminin to block DNA replication, two 
events are required. First, Geminin must homodimerize via a 
coiled-coil motif in its central region to be capable of binding 
to Cdt1 (77). Second, the Geminin homodimer must bind Cdt1 
?????????? via interaction of two domains of Geminin with two 
domains of Cdt1, which we will refer to as domains I and II in 
Geminin (77)(Fig-19, top left diagram). Using the work of Dutta 
and colleagues as a reference (77), we have generated four 
important mutants of Geminin for testing in our chromatin 
???????????????????????????? ???????????????????????? ????????
(Gem-LZ), and cannot bind Cdt1 nor block DNA replication. 
Another, Gem(92-152)?????????????????????? ???????????????????????????????????????????????????????????????????????
domain II), but cannot block DNA replication. The third, Gem(70-152), is capable of homodimerizing, binding Cdt1 
???????????????????????????????????????????????? ??????????????????????????? ??????? ??????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????
has lost its destruction box (77, 108). These mutants cover a wide range of Geminin characteristics and therefore 
represent a very attractive means to test the physiological and biochemical interplay between Cdt1-binding, DNA 
replication inhibition, and chromatin remodeling control by Geminin.
 We will test each of the above mutants for their ability to block or reduce the chromatin remodeling induced 
by targeting LacI-Cdt1 to the HSR in the Belmont decondensation assays (3)(Fig-19, note question marks at far 
right). This will involve co-transfecting HA-tagged versions of each Geminin mutant along with LacI-Cdt1, or 
LacI-Cdt1 with empty vector as a control. Prior to this, HA-tagged mutants of Geminin will be tested by transient 
transfections and immunoblotting with anti-HA antibodies to verify equal expression of each mutant in our 
hands. Any differences in expression will be compensated for by changing the amount of individual HA-Geminin 
mutant co-expressed with LacI-Cdt1. A03_1 cells growing on coverslips in 35 mm plates will be transiently co-
???????????? ???????????? ?????????????????????????????????????? ???? ??????????????????????? ? ????????????????
(3). Anti-LacI polyclonal antibody (Stratagene) will be used to identify the LacI-Cdt1 proteins and thus detect 
the open or closed (or partial) chromatin structures at the HSRs. We will examine minimally 150 transfected 
cells for each condition. As done previously (3), we will score three appearances of the chromatin sites: clearly 
open, clearly closed, and indeterminate (which are not obviously open or closed), and plot the percentage of 
each seen for each condition. Open chromatin HSRs will imply that a given Geminin allele is not capable of 
blocking chromatin opening by Cdt1. Closed HSRs will suggest that a given Geminin allele is potent at preventing 
and/or closing Cdt1-induced chromatin unfolding. Indeterminate do not support either interpretation. Wildtype 
Geminin will serve as a positive control for blocking Cdt1 chromatin unfolding.
 As shown in our Preliminary Results (Fig-9), wildtype Geminin not only blocks Cdt1-induced remodeling 
(producing closed dots), but also suppresses the degree to which Cdt1 can cause opening (producing small-open 
structures that are less robust in size versus control samples). Therefore, we will also determine whether the 
size of any open HSRs is large-open or small-open following Geminin mutant co-expression with LacI-Cdt1. 
This is important, because we are co-expressing exogenous Geminin mutants that act stoichiometrically against 
Cdt1 (77), and which may not be able to overcome the cellular limitations that normally down-regulate Geminin 
function (e.g., in G1 phase when Geminin is degraded (40)). This analysis is similar to that published by another 
group in which mutant alleles of BRCA1 were scored as being more or less robust at opening chromatin (107). 
Our analysis will be scored by two people, and multiple representative photographs will be obtained to illustrate 
the differences we are observing (such as those shown in Fig-9). An increase in the presence of small-open HSRs, 
but not a total shift toward closed structures, will be interpreted to mean that a given Geminin allele can suppress 
Cdt1-induced chromatin unfolding, but not completely.
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Fig. 42 Geminin Mutants.  Schematic of the Geminin mutants to be analyzed.  
105
Modulation of Cdt1 Function by HBO1 and HDAC11
 We have shown that HBO1 and HDAC11 are crucial regulators of Cdt1-
dependent chromatin remodeling, and others have demonstrated the importance of HBO1 
activity to replication licensing (Iizuka et al. 2006; Miotto and Struhl 2010).  HBO1 and 
HDAC11 both directly interact with Cdt1 (Glozak and Seto 2009; Miotto and Struhl 
2010), however the precise domain or region of Cdt1 where these interactions take place 
have yet to be clearly identified.  To this end, we plan to perform co-immunoprecipitation 
assays using full length HBO1 and HDAC11 with a panel of Cdt1 deletion mutants that 
we have already generated (Fig. 43).  We have analyzed these mutants in terms of their 
ability  to mediate chromatin unfolding (data not shown) and have found Cdt1 Δ201-355 
to be dysfunctional in not only chromatin remodeling capability (Fig. 26), but also 
impaired in its ability  to maintain survival in long-term colony growth assays (Fig. 27) 
and in its ability  to stimulate re-replication (Fig. 28).  However, identifying specific 
regions on Cdt1 responsible for HBO1 and/or HDAC11 binding represents an important 
step in understanding the molecular basis of these interactions and the potential influence 
other proteins (i.e. Geminin) may have in modulating them.    
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LacI-VP16 into separate plates and perform parallel assays alongside that of LacI-Cdt1. 
? ??? ??????????? ????????????????????????????????????????? ???????????????????????????????????????????????
?????????? ?????????????????????????? ?? ??? ??????????????????? ?????????????????? ????????????????? ?? ????????????
???????????????????????????? ????????????????????????????????????????????????????? ????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????
????? ????? ????????????????????????????????? ??????? ?????????????????????? ???? ??????????????????????????
????????????????????? ????????????????? ??????????????????????????????????? ????????? ??? ??????????????????????
Microscopy Core facility) to obtain 0.5 !M layer scans on individual cells through the open chromatin structures 
??????????????????????????????????????????????????????????????????????????????????????????????????????????????
Colocalization/enrichment will be indicated by yellow color appearing in merged images. We will analyze 150 
?????? ??? ??????????????????????????????????????? ???????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????
??????????????? ??????????? ???????????? ????????????????????????????????????????????????????????????????????
(and would give clues as to the enzyme that may have been recruited). Lack of enrichment may indicate that the 
????????????????????????????????????????????????????????
?? ?????????????????????????????? ?????????????????????????????????????????????????????????????????????????
in these colocalization assays (72, 82). We will again use anti-H4-AcLys-5,8,12,16 (so-called Penta antibody) and 
???????????????????????????????????????????????????????????? ???????????????????????????????????????? ??????????
????????????????????????????? ????????? ?????? ????????????????????? ????? ????? ??????????? ????????????????????
(3); H2A-AcLys-5; H2A-AcLys-9; H2B-AcLys-5; H2B-AcLys-12; H3-MeLys-36; H3-MeLys-79; and H3-MeLys-
4 (for methyl antibodies, mono-, di-, and tri-methylated versions will be tested). We will only test anti-acetyl 
antibodies in TSA experiments, but all antibodies will be tested at 10, 12, 14, and 24 hrs after LacI-Cdt1 or 
LacI-VP16 transfections, since even the methylation or phosphorylation changes may be transient. In each of 
these cases, antibodies are already in-hand (and tested against CHO species), or will be purchased from Upstate 
Biotech, Inc., or obtained from our collaborator (Ed Seto). Anti-H3-Me3Lys-9 and anti-H3-Me3Lys-20 (both 
??? ????????????????????????????????????????????????????????????????????????????????????????????????????????????
not colocalize with any of the open sites (56). Many of these histone changes are likely to colocalize with VP16-
opened sites (3, 107), and such colocalization with VP16 will thus serve as a positive control.
??????????????????????? ??????????????????????????????????????????????????????? ???????
 We have created 13 mutants of Cdt1 that progressively lack 50-100 amino acid 
stretches throughout the 546 aa coding region (Fig. N20). The mutant alleles have been 
tested to verify the predicted protein can be expressed. We have them HA-tagged and 
LacI-tagged. A new anti-Cdt1 antibody (see Fig. N21) has been used successfully on 
immunblots of the LacI-tagged versions to verify that they are indeed Cdt1 derivatives 
(data not shown). We will test these deletion mutants of Cdt1 for functionality (or 
not) in three experimental approaches: ??? chromatin remodeling ability in A03_1 
cells; ???? ability to co-IP/bind to HBO1 and HDAC11 in 293T cells; and ????? ability 
to promote  re-replication in H1299 cells. For assessing the chromatin remodeling 
potential of each mutant, we will employ the Belmont chromatin unfolding system 
(A03_1 cells) used above in SA2 (3). The positive control will be full-length Cdt1, and 
negative control will be pRcLac expressing LacI alone (no remodeling occurs). We 
will examine minimally 150 transfected cells for each mutant using the same IF assay 
as above. We will score three appearances of the chromatin sites (3): clearly open, 
?????????????????????????????????????????????????????????????????? ????? ????? ?????????
???????? ??????????????????????????????????????????????????????? ????????????????????????? ?????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????
support either interpretation.
 Testing the ability of each Cdt1 mutant to bind HBO1 or HDAC11 will utilize the same co-IP approach 
described above in SA2. HA-tagged Cdt1 mutants will be co-transfected into 293T cells with FLAG-tagged 
HBO1 or HDAC11, and anti-HA antibodies will be used to IP the Cdt1 mutant proteins and any other associated 
proteins. Proteins will be separated on acrylamide gels, transferred to membranes, and probed with antibodies 
to FLAG to determine if HBO1 or HDAC11 can bind (or not) to the tested Cdt1 mutant protein. Wildtype Cdt1 
will be transfected as a positive control for binding to both HBO1 and HDAC11 as in our Preliminary co-IP assays 
above. A sample of each lysate following co-transfection will be immunoblotted without the IP step (i.e., input) 
to verify equal expression of each protein during the experiment. ??? ??????????????????????????????????????????????
of the same combinations to test for the direct nature of these interactions in vitro (approach will be as in SA2). 
The presence of HBO1 or HDAC11 on immunoblots after the Cdt1-IP step will indicate that the tested Cdt1 allele 
remains capable of interacting with either enzyme. Lack of HBO1/HDAC11 on such immunoblots will indicate 
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Fig-N20: Cdt1 mutants now 
constructed by us for use in 
this study. 
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Fig. 43 Cdt1 Deletion Mutants.  
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??????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????? ??????????????????????????????? ?????????? ????????????become 
chromatin-bound during the time interval of 6-12 hrs, which is also the interval of accumulation for Cdc6 and 
????????????????? ?????????????????????????? ???????????????????????????????? ??????????????????????????????????
????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????
??????????? ?? ????????????? ???????????? ??????????????? ?????????????? ???? ???? ???????????? ????????? ?? ????????
??? ????????????????? ???????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????? ?????????????????????????? ???????
MCM loading, but then not being necessary on chromatin after the MCMs have loaded. Interestingly, the band 
??????????????? ????????????????????????????????????????????????????? ???????????and? ???????????????????????
where it is seen that accumulation begins slightly at 9 hrs and continues increasing up to the last time point of 
??????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????? ?????????????????????????????????????
??????????? ????????? ???????? ??????????? ?????????? ???????? ???? ???????????????? ?? ??????
?????????? ????????????? ?????????? ???????????????????????????????????????? ???????????????
????? ??????????????????????? ???????????????????????????? ??????????enzymatic activity also 
increases during G1 when MCMs load (45).
HBO1, like Cdt1, is required for MCM loading and S-phase entry, and HDAC11 
????????????????????????????????? ?????????????????????????
 ???????????????????????????????????????????????????????????????????????????????????
???????????????????????????????? ??????????????????????? ??????????????????????????
and Xenopus? ?????????? ?????????? ????????????? ?????? ??? ?????????? ? ?????????????? ???
?????????????????????????????????Xenopus system (45) (but was not tested in mammalian 
????????????????? ??? ????????? ???????????????????????? ????????????? ??????????????????????
phase entry. These results are entirely consistent with our hypothesis and preliminary data 
???????????????? ???? ???????????????????????????????????????????????????????? ????????????
?????????????????????????????????????????? ???????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????? ?????????
??? ????? ????? ??? ?????? ??? ?? ??????? ??????????? ???????? ?????? ???????????????????????????
??????????????????????????????????????????????????????????? ?????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????? ??????????????????????????????????????
??????????????????? ???????????????? ????????????????????????????? ????? ????????
????????????????????????????????????????????????????????????????????????????????
????????????????????????? ?????????????????????????????? ?????????? ??????????
???????????????????????????????????????????????????????????????????????????
??????????? ???????????????????????? ????????? ??????????? 
Establishment of Bimolecular Fluorescent Complementation 
between Geminin and Cdt1
? ????????????????????in vivo Geminin-Cdt1 interactions as they pertain 
??????????????????????????????????? ??????????????????????????????in vivo 
protein-protein interaction technique established in the Kerppola laboratory 
????? ???? ???? ??????? ?????? ? ????????? ???????????? ???????????????
???????? ????????? ???????? ???? ???????? ????? ????? ??? ????????? ???????
???????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????
the two proteins can interact in vivo, then yellow light will be generated 
????????????????????????????????????????? ??????????????????????? ????
????????????????????????????????????????????????????????????????????????
????????????? ?????? ???? ?????????? ????? ???? ???????????? ??????? ???
Fos was deleted (41). The system recapitulates published information 
?????????? ????????????????? ????????????? ?????? ??? ????? ??????????
??????????????????????????????????????????????? ??????????????????????
???????????? ???????????????????????????????????????????????????????
???????????????????? ????????????????????????????????????????????????
????? ????? ????????????? ???? ?????????? ?????????????? ???????????? ???????
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Fig. 44 HDAC11 Specifically Blocks S-phase.  HDAC1 or HDAC11 (or none) were 
expressed for 24 hours in CHO cells.  BrdU was pulsed for the last 30 minutes.  BrdU 
labeling indices were determined for each condition.  
 To further our understanding of HDAC11’s role in licensing control, it will be 
important to examine the effects of HDAC11 enzymatic disruption on HDAC11 
inhibition of Cdt1-induced chromatin remodeling, HDAC11 inhibition of Cdt1-induced 
re-replication (Fig. 10), and HDAC11 inhibition of replication (Figs. 11&44).  RNAi 
knockdown of HDAC11, drug-mediated enzymatic inhibition (eg TSA), or generation of 
108
a catalytically  dead HDAC11 mutant all represent viable methods by which to induce 
HDAC11 dysfunction.  If HDAC11 is an essential regulator of Cdt1 function, disrupting 
this negative control could potentially result in a similar manner to overexpressing Cdt1 
alone in each assay.    
 Overall, the field of replication licensing and G1-S control represent an important 
avenue of basic cancer research, both in terms of understanding fundamental disease 
biology  and in the identification of potential drug targets.  Precise coordination of the 
events leading up to DNA replication initiation is absolutely crucial to maintaining 
genomic stability.  As such, multiple levels of control exist to regulate the cell cycle 
machinery  entrusted with copying the genetic information of a cell in its entirety, without 
error.  The complexity  and the elegance of such a vital network of molecular signals is 
awe-inspiring.  As research in this field progresses, the details of this intricate regulatory 
mechanism will slowly be revealed and I can only hope that the full scope of chromatin 
fluidity-based regulation of replication licensing will be unearthed.  
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